-
1
-
-
84912031921
-
Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease
-
25429318 4243154
-
Yoon HJ, Cha BS (2014) Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease. World J Hepatol 6:800-811
-
(2014)
World J Hepatol
, vol.6
, pp. 800-811
-
-
Yoon, H.J.1
Cha, B.S.2
-
2
-
-
84864390922
-
The epidemiology, pathogenesis and histopathology of fatty liver disease
-
22372457
-
Levene AP, Goldin RD (2012) The epidemiology, pathogenesis and histopathology of fatty liver disease. Histopathology 61:141-152
-
(2012)
Histopathology
, vol.61
, pp. 141-152
-
-
Levene, A.P.1
Goldin, R.D.2
-
3
-
-
84930854845
-
Non-alcoholic fatty liver disease in 2015
-
26085906 4462685
-
Ahmed M (2015) Non-alcoholic fatty liver disease in 2015. World J Hepatol 7:1450-1459
-
(2015)
World J Hepatol
, vol.7
, pp. 1450-1459
-
-
Ahmed, M.1
-
4
-
-
77950323927
-
Pathogenesis of non-alcoholic fatty liver disease
-
1:STN:280:DC%2BC3c%2FjvFGhtA%3D%3D 19914930 2810391
-
Dowman JK, Tomlinson JW, Newsome PN (2010) Pathogenesis of non-alcoholic fatty liver disease. QJM 103:71-83
-
(2010)
QJM
, vol.103
, pp. 71-83
-
-
Dowman, J.K.1
Tomlinson, J.W.2
Newsome, P.N.3
-
5
-
-
84862883948
-
Nonalcoholic fatty liver disease/steatohepatitis: Epidemiology, pathogenesis, clinical presentation and treatment
-
22722431
-
Milic S, Stimac D (2012) Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment. Dig Dis 30:158-162
-
(2012)
Dig Dis
, vol.30
, pp. 158-162
-
-
Milic, S.1
Stimac, D.2
-
6
-
-
84901921708
-
Steatosis and steatohepatitis: Complex disorders
-
1:CAS:528:DC%2BC2MXjtFymur8%3D 24897026 4100130
-
Bettermann K, Hohensee T, Haybaeck J (2014) Steatosis and steatohepatitis: complex disorders. Int J Mol Sci 15:9924-9944
-
(2014)
Int J Mol Sci
, vol.15
, pp. 9924-9944
-
-
Bettermann, K.1
Hohensee, T.2
Haybaeck, J.3
-
7
-
-
78650486196
-
Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study
-
20858492
-
Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA (2011) Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140:124-131
-
(2011)
Gastroenterology
, vol.140
, pp. 124-131
-
-
Williams, C.D.1
Stengel, J.2
Asike, M.I.3
Torres, D.M.4
Shaw, J.5
Contreras, M.6
Landt, C.L.7
Harrison, S.A.8
-
8
-
-
35848932768
-
Prevalence of non-alcoholic fatty liver disease: Population based study
-
17786142
-
Amarapurkar D, Kamani P, Patel N, Gupte P, Kumar P, Agal S, Baijal R, Lala S, Chaudhary D, Deshpande A (2007) Prevalence of non-alcoholic fatty liver disease: population based study. Ann Hepatol 6:161-163
-
(2007)
Ann Hepatol
, vol.6
, pp. 161-163
-
-
Amarapurkar, D.1
Kamani, P.2
Patel, N.3
Gupte, P.4
Kumar, P.5
Agal, S.6
Baijal, R.7
Lala, S.8
Chaudhary, D.9
Deshpande, A.10
-
9
-
-
77649337140
-
Nonalcoholic fatty liver disease: Pathology and pathogenesis
-
1:CAS:528:DC%2BC3cXivFekt7s%3D 20078219
-
Tiniakos DG, Vos MB, Brunt EM (2010) Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 5:145-171
-
(2010)
Annu Rev Pathol
, vol.5
, pp. 145-171
-
-
Tiniakos, D.G.1
Vos, M.B.2
Brunt, E.M.3
-
10
-
-
44649095633
-
Review article: Current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
-
1:CAS:528:DC%2BD1cXovFelsb0%3D 18410557
-
Younossi ZM (2008) Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther 28:2-12
-
(2008)
Aliment Pharmacol Ther
, vol.28
, pp. 2-12
-
-
Younossi, Z.M.1
-
11
-
-
84880425040
-
Epidemiology and natural history of patients with NAFLD
-
1:CAS:528:DC%2BC3sXht1GmsLvL 23394091
-
Bhala N, Jouness RI, Bugianesi E (2013) Epidemiology and natural history of patients with NAFLD. Curr Pharm Des 19:5169-5176
-
(2013)
Curr Pharm des
, vol.19
, pp. 5169-5176
-
-
Bhala, N.1
Jouness, R.I.2
Bugianesi, E.3
-
12
-
-
84861543083
-
The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
-
22488764
-
Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55:2005-2023
-
(2012)
Hepatology
, vol.55
, pp. 2005-2023
-
-
Chalasani, N.1
Younossi, Z.2
Lavine, J.E.3
Diehl, A.M.4
Brunt, E.M.5
Cusi, K.6
Charlton, M.7
Sanyal, A.J.8
-
13
-
-
67649306197
-
Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
-
1:CAS:528:DC%2BD1MXnvVams7g%3D 19501928
-
Argo CK, Northup PG, Al-Osaimi AM, Caldwell SH (2009) Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol 51:371-379
-
(2009)
J Hepatol
, vol.51
, pp. 371-379
-
-
Argo, C.K.1
Northup, P.G.2
Al-Osaimi, A.M.3
Caldwell, S.H.4
-
14
-
-
77951456114
-
Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection
-
20432259
-
Starley BQ, Calcagno CJ, Harrison SA (2010) Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 51:1820-1832
-
(2010)
Hepatology
, vol.51
, pp. 1820-1832
-
-
Starley, B.Q.1
Calcagno, C.J.2
Harrison, S.A.3
-
15
-
-
84922622191
-
A concise review of non-alcoholic fatty liver disease
-
1:CAS:528:DC%2BC2MXotVOkuw%3D%3D 25617860
-
Than NN, Newsome PN (2015) A concise review of non-alcoholic fatty liver disease. Atherosclerosis 239:192-202
-
(2015)
Atherosclerosis
, vol.239
, pp. 192-202
-
-
Than, N.N.1
Newsome, P.N.2
-
16
-
-
75449102165
-
Long-term mortality in nonalcoholic fatty liver disease: Is liver histology of any prognostic significance?
-
20101746 2945376
-
Angulo P (2010) Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance? Hepatology 51:373-375
-
(2010)
Hepatology
, vol.51
, pp. 373-375
-
-
Angulo, P.1
-
17
-
-
33750606061
-
Long-term follow-up of patients with NAFLD and elevated liver enzymes
-
1:CAS:528:DC%2BD28XhtFyqsrzN 17006923
-
Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, Kechagias S (2006) Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44:865-873
-
(2006)
Hepatology
, vol.44
, pp. 865-873
-
-
Ekstedt, M.1
Franzen, L.E.2
Mathiesen, U.L.3
Thorelius, L.4
Holmqvist, M.5
Bodemar, G.6
Kechagias, S.7
-
18
-
-
22344452893
-
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
-
16012941
-
Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P (2005) The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129:113-121
-
(2005)
Gastroenterology
, vol.129
, pp. 113-121
-
-
Adams, L.A.1
Lymp, J.F.2
St Sauver, J.3
Sanderson, S.O.4
Lindor, K.D.5
Feldstein, A.6
Angulo, P.7
-
19
-
-
0036894480
-
NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States
-
12447858
-
Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS (2002) NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 36:1349-1354
-
(2002)
Hepatology
, vol.36
, pp. 1349-1354
-
-
Marrero, J.A.1
Fontana, R.J.2
Su, G.L.3
Conjeevaram, H.S.4
Emick, D.M.5
Lok, A.S.6
-
20
-
-
0019152816
-
Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease
-
1:STN:280:DyaL3c3gvVeqtQ%3D%3D 7382552
-
Ludwig J, Viggiano TR, McGill DB, Oh BJ (1980) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55:434-438
-
(1980)
Mayo Clin Proc
, vol.55
, pp. 434-438
-
-
Ludwig, J.1
Viggiano, T.R.2
McGill, D.B.3
Oh, B.J.4
-
21
-
-
0031947715
-
Steatohepatitis: A tale of two "hits"?
-
1:STN:280:DyaK1c3htFartQ%3D%3D 9547102
-
Day CP, James OF (1998) Steatohepatitis: a tale of two "hits"? Gastroenterology 114:842-845
-
(1998)
Gastroenterology
, vol.114
, pp. 842-845
-
-
Day, C.P.1
James, O.F.2
-
22
-
-
84859404868
-
Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: Pathophysiology and clinical implications
-
Cusi K (2012) Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology 142(711-725):e716
-
(2012)
Gastroenterology
, vol.142
, Issue.711-725
, pp. e716
-
-
Cusi, K.1
-
23
-
-
77955690182
-
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites
-
20683968
-
Neuschwander-Tetri BA (2010) Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 52:774-788
-
(2010)
Hepatology
, vol.52
, pp. 774-788
-
-
Neuschwander-Tetri, B.A.1
-
24
-
-
77950863893
-
Nontriglyceride hepatic lipotoxicity: The new paradigm for the pathogenesis of NASH
-
20425484
-
Neuschwander-Tetri BA (2010) Nontriglyceride hepatic lipotoxicity: the new paradigm for the pathogenesis of NASH. Curr Gastroenterol Rep 12:49-56
-
(2010)
Curr Gastroenterol Rep
, vol.12
, pp. 49-56
-
-
Neuschwander-Tetri, B.A.1
-
25
-
-
78049522194
-
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
-
1:CAS:528:DC%2BC3cXhsFOnsrjP 21038418
-
Tilg H, Moschen AR (2010) Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52:1836-1846
-
(2010)
Hepatology
, vol.52
, pp. 1836-1846
-
-
Tilg, H.1
Moschen, A.R.2
-
26
-
-
84878613524
-
Review article: Is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?
-
1:CAS:528:DC%2BC3sXjtVOltQ%3D%3D 22966992
-
Yilmaz Y (2012) Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions? Aliment Pharmacol Ther 36:815-823
-
(2012)
Aliment Pharmacol Ther
, vol.36
, pp. 815-823
-
-
Yilmaz, Y.1
-
27
-
-
84927800692
-
Non-alcoholic fatty liver - Perhaps not so benign
-
25681555
-
Adams LA, Ratziu V (2015) Non-alcoholic fatty liver - perhaps not so benign. J Hepatol 62:1002-1004
-
(2015)
J Hepatol
, vol.62
, pp. 1002-1004
-
-
Adams, L.A.1
Ratziu, V.2
-
28
-
-
84927796763
-
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
-
25477264
-
McPherson S, Hardy T, Henderson E, Burt AD, Day CP, Anstee QM (2015) Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. J Hepatol 62:1148-1155
-
(2015)
J Hepatol
, vol.62
, pp. 1148-1155
-
-
McPherson, S.1
Hardy, T.2
Henderson, E.3
Burt, A.D.4
Day, C.P.5
Anstee, Q.M.6
-
29
-
-
77952635912
-
Understanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease
-
20458758 2868214
-
Basaranoglu M, Kayacetin S, Yilmaz N, Kayacetin E, Tarcin O, Sonsuz A (2010) Understanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol 16:2223-2226
-
(2010)
World J Gastroenterol
, vol.16
, pp. 2223-2226
-
-
Basaranoglu, M.1
Kayacetin, S.2
Yilmaz, N.3
Kayacetin, E.4
Tarcin, O.5
Sonsuz, A.6
-
30
-
-
33748110788
-
Hepatic histology in obese patients undergoing bariatric surgery
-
16899321
-
Machado M, Marques-Vidal P, Cortez-Pinto H (2006) Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol 45:600-606
-
(2006)
J Hepatol
, vol.45
, pp. 600-606
-
-
Machado, M.1
Marques-Vidal, P.2
Cortez-Pinto, H.3
-
31
-
-
0037129380
-
Nonalcoholic fatty liver disease
-
1:CAS:528:DC%2BD38XivVOmsrY%3D 11961152
-
Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221-1231
-
(2002)
N Engl J Med
, vol.346
, pp. 1221-1231
-
-
Angulo, P.1
-
32
-
-
84930656108
-
NAFLD: A multisystem disease
-
25920090
-
Byrne CD, Targher G (2015) NAFLD: a multisystem disease. J Hepatol 62:S47-S64
-
(2015)
J Hepatol
, vol.62
, pp. S47-S64
-
-
Byrne, C.D.1
Targher, G.2
-
33
-
-
84878930738
-
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
-
1:CAS:528:DC%2BC3sXptVOlsrs%3D 23507799
-
Anstee QM, Targher G, Day CP (2013) Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 10:330-344
-
(2013)
Nat Rev Gastroenterol Hepatol
, vol.10
, pp. 330-344
-
-
Anstee, Q.M.1
Targher, G.2
Day, C.P.3
-
34
-
-
84896690517
-
Extrahepatic complications of nonalcoholic fatty liver disease
-
1:CAS:528:DC%2BC2cXjsVeltLs%3D 24002776
-
Armstrong MJ, Adams LA, Canbay A, Syn WK (2014) Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology 59:1174-1197
-
(2014)
Hepatology
, vol.59
, pp. 1174-1197
-
-
Armstrong, M.J.1
Adams, L.A.2
Canbay, A.3
Syn, W.K.4
-
35
-
-
84943540060
-
Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders
-
26310987
-
Lim S, Oh TJ, Koh KK (2015) Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders. Int J Cardiol 201:408-414
-
(2015)
Int J Cardiol
, vol.201
, pp. 408-414
-
-
Lim, S.1
Oh, T.J.2
Koh, K.K.3
-
36
-
-
84884508163
-
A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?
-
1:CAS:528:DC%2BC3sXhsFemsL%2FP 24075754
-
Oni ET, Agatston AS, Blaha MJ, Fialkow J, Cury R, Sposito A, Erbel R, Blankstein R, Feldman T, Al-Mallah MH, Santos RD, Budoff MJ, Nasir K (2013) A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care? Atherosclerosis 230:258-267
-
(2013)
Atherosclerosis
, vol.230
, pp. 258-267
-
-
Oni, E.T.1
Agatston, A.S.2
Blaha, M.J.3
Fialkow, J.4
Cury, R.5
Sposito, A.6
Erbel, R.7
Blankstein, R.8
Feldman, T.9
Al-Mallah, M.H.10
Santos, R.D.11
Budoff, M.J.12
Nasir, K.13
-
37
-
-
84909631649
-
Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic
-
1:CAS:528:DC%2BC2cXhvFSksr%2FM 25232245 4161796
-
Hassan K, Bhalla V, Ezz El Regal M, A-Kader HH (2014) Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic. World J Gastroenterol 20:12082-12101
-
(2014)
World J Gastroenterol
, vol.20
, pp. 12082-12101
-
-
Hassan, K.1
Bhalla, V.2
Ezz El Regal, M.3
A-Kader, H.H.4
-
38
-
-
50549084740
-
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
-
18682312
-
Ong JP, Pitts A, Younossi ZM (2008) Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol 49:608-612
-
(2008)
J Hepatol
, vol.49
, pp. 608-612
-
-
Ong, J.P.1
Pitts, A.2
Younossi, Z.M.3
-
39
-
-
84937522427
-
Hepatokines: Unlocking the multi-organ network in metabolic diseases
-
1:CAS:528:DC%2BC2MXps1ehsrc%3D 26032022
-
Iroz A, Couty JP, Postic C (2015) Hepatokines: unlocking the multi-organ network in metabolic diseases. Diabetologia 58:1699-1703
-
(2015)
Diabetologia
, vol.58
, pp. 1699-1703
-
-
Iroz, A.1
Couty, J.P.2
Postic, C.3
-
40
-
-
84875549943
-
The role of hepatokines in metabolism
-
1:CAS:528:DC%2BC3sXjtVaktb4%3D 23337953
-
Stefan N, Haring HU (2013) The role of hepatokines in metabolism. Nat Rev Endocrinol 9:144-152
-
(2013)
Nat Rev Endocrinol
, vol.9
, pp. 144-152
-
-
Stefan, N.1
Haring, H.U.2
-
41
-
-
84923239473
-
Hepatokines as a link between obesity and cardiovascular diseases
-
25729707 4342531
-
Yoo HJ, Choi KM (2015) Hepatokines as a link between obesity and cardiovascular diseases. Diabetes Metab J 39:10-15
-
(2015)
Diabetes Metab J
, vol.39
, pp. 10-15
-
-
Yoo, H.J.1
Choi, K.M.2
-
42
-
-
78449301931
-
Serum fetuin A/alpha2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: Relation with liver fibrosis
-
20926473
-
Yilmaz Y, Yonal O, Kurt R, Ari F, Oral AY, Celikel CA, Korkmaz S, Ulukaya E, Ozdogan O, Imeryuz N, Avsar E, Kalayci C (2010) Serum fetuin A/alpha2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis. Ann Clin Biochem 47:549-553
-
(2010)
Ann Clin Biochem
, vol.47
, pp. 549-553
-
-
Yilmaz, Y.1
Yonal, O.2
Kurt, R.3
Ari, F.4
Oral, A.Y.5
Celikel, C.A.6
Korkmaz, S.7
Ulukaya, E.8
Ozdogan, O.9
Imeryuz, N.10
Avsar, E.11
Kalayci, C.12
-
43
-
-
84907638181
-
Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease
-
24797980
-
Lebensztejn DM, Bialokoz-Kalinowska I, Klusek-Oksiuta M, Tarasow E, Wojtkowska M, Kaczmarski M (2014) Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease. Adv Med Sci 59:81-84
-
(2014)
Adv Med Sci
, vol.59
, pp. 81-84
-
-
Lebensztejn, D.M.1
Bialokoz-Kalinowska, I.2
Klusek-Oksiuta, M.3
Tarasow, E.4
Wojtkowska, M.5
Kaczmarski, M.6
-
44
-
-
77956519052
-
Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease
-
1:CAS:528:DC%2BC3cXhtlSgtrnN 20624171
-
Yilmaz Y, Eren F, Yonal O, Kurt R, Aktas B, Celikel CA, Ozdogan O, Imeryuz N, Kalayci C, Avsar E (2010) Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease. Eur J Clin Invest 40:887-892
-
(2010)
Eur J Clin Invest
, vol.40
, pp. 887-892
-
-
Yilmaz, Y.1
Eren, F.2
Yonal, O.3
Kurt, R.4
Aktas, B.5
Celikel, C.A.6
Ozdogan, O.7
Imeryuz, N.8
Kalayci, C.9
Avsar, E.10
-
45
-
-
77957359658
-
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
-
1:CAS:528:DC%2BC3cXht1Cmu77E 20675007
-
Li H, Fang Q, Gao F, Fan J, Zhou J, Wang X, Zhang H, Pan X, Bao Y, Xiang K, Xu A, Jia W (2010) Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride. J Hepatol 53:934-940
-
(2010)
J Hepatol
, vol.53
, pp. 934-940
-
-
Li, H.1
Fang, Q.2
Gao, F.3
Fan, J.4
Zhou, J.5
Wang, X.6
Zhang, H.7
Pan, X.8
Bao, Y.9
Xiang, K.10
Xu, A.11
Jia, W.12
-
46
-
-
77955474305
-
Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease
-
1:CAS:528:DC%2BC3cXpsVGnu74%3D 20451522
-
Dushay J, Chui PC, Gopalakrishnan GS, Varela-Rey M, Crawley M, Fisher FM, Badman MK, Martinez-Chantar ML, Maratos-Flier E (2010) Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. Gastroenterology 139:456-463
-
(2010)
Gastroenterology
, vol.139
, pp. 456-463
-
-
Dushay, J.1
Chui, P.C.2
Gopalakrishnan, G.S.3
Varela-Rey, M.4
Crawley, M.5
Fisher, F.M.6
Badman, M.K.7
Martinez-Chantar, M.L.8
Maratos-Flier, E.9
-
47
-
-
84874952628
-
Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic Fatty liver disease
-
23439771 3579154
-
Choi HY, Hwang SY, Lee CH, Hong HC, Yang SJ, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM (2013) Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic Fatty liver disease. Diabetes Metab J 37:63-71
-
(2013)
Diabetes Metab J
, vol.37
, pp. 63-71
-
-
Choi, H.Y.1
Hwang, S.Y.2
Lee, C.H.3
Hong, H.C.4
Yang, S.J.5
Yoo, H.J.6
Seo, J.A.7
Kim, S.G.8
Kim, N.H.9
Baik, S.H.10
Choi, D.S.11
Choi, K.M.12
-
48
-
-
79961235988
-
Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: Implications for insulin resistance, inflammation, and atherosclerosis
-
1:CAS:528:DC%2BC3MXhtVKhsb3F 21677040
-
Yang SJ, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM (2011) Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. J Clin Endocrinol Metab 96:E1325-E1329
-
(2011)
J Clin Endocrinol Metab
, vol.96
, pp. E1325-E1329
-
-
Yang, S.J.1
Hwang, S.Y.2
Choi, H.Y.3
Yoo, H.J.4
Seo, J.A.5
Kim, S.G.6
Kim, N.H.7
Baik, S.H.8
Choi, D.S.9
Choi, K.M.10
-
49
-
-
84885039863
-
Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors
-
1:CAS:528:DC%2BC3sXhsVens7rN 23887638
-
Chow WS, Xu A, Woo YC, Tso AW, Cheung SC, Fong CH, Tse HF, Chau MT, Cheung BM, Lam KS (2013) Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors. Arterioscler Thromb Vasc Biol 33:2454-2459
-
(2013)
Arterioscler Thromb Vasc Biol
, vol.33
, pp. 2454-2459
-
-
Chow, W.S.1
Xu, A.2
Woo, Y.C.3
Tso, A.W.4
Cheung, S.C.5
Fong, C.H.6
Tse, H.F.7
Chau, M.T.8
Cheung, B.M.9
Lam, K.S.10
-
50
-
-
84883118811
-
Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease
-
23981342 3766150
-
Shen Y, Ma X, Zhou J, Pan X, Hao Y, Zhou M, Lu Z, Gao M, Bao Y, Jia W (2013) Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease. Cardiovasc Diabetol 12:124
-
(2013)
Cardiovasc Diabetol
, vol.12
, pp. 124
-
-
Shen, Y.1
Ma, X.2
Zhou, J.3
Pan, X.4
Hao, Y.5
Zhou, M.6
Lu, Z.7
Gao, M.8
Bao, Y.9
Jia, W.10
-
51
-
-
58149393662
-
Plasma fetuin - A levels and the risk of myocardial infarction and ischemic stroke
-
1:CAS:528:DC%2BD1cXhsVerurrM 19029462
-
Weikert C, Stefan N, Schulze MB, Pischon T, Berger K, Joost HG, Haring HU, Boeing H, Fritsche A (2008) Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 118:2555-2562
-
(2008)
Circulation
, vol.118
, pp. 2555-2562
-
-
Weikert, C.1
Stefan, N.2
Schulze, M.B.3
Pischon, T.4
Berger, K.5
Joost, H.G.6
Haring, H.U.7
Boeing, H.8
Fritsche, A.9
-
52
-
-
84873533674
-
Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease
-
1:CAS:528:DC%2BC3sXlvVeks7s%3D
-
Dogru T, Genc H, Tapan S, Aslan F, Ercin CN, Ors F, Kara M, Sertoglu E, Karslioglu Y, Bagci S, Kurt I, Sonmez A (2013) Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf) 78:712-717
-
(2013)
Clin Endocrinol (Oxf)
, vol.78
, pp. 712-717
-
-
Dogru, T.1
Genc, H.2
Tapan, S.3
Aslan, F.4
Ercin, C.N.5
Ors, F.6
Kara, M.7
Sertoglu, E.8
Karslioglu, Y.9
Bagci, S.10
Kurt, I.11
Sonmez, A.12
-
53
-
-
18244382304
-
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
-
1:CAS:528:DC%2BD2MXktFSktLk%3D 15864352 1087172
-
Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115:1343-1351
-
(2005)
J Clin Invest
, vol.115
, pp. 1343-1351
-
-
Donnelly, K.L.1
Smith, C.I.2
Schwarzenberg, S.J.3
Jessurun, J.4
Boldt, M.D.5
Parks, E.J.6
-
54
-
-
79959517565
-
Human fatty liver disease: Old questions and new insights
-
1:CAS:528:DC%2BC3MXnsleiurY%3D 21700865 3229276
-
Cohen JC, Horton JD, Hobbs HH (2011) Human fatty liver disease: old questions and new insights. Science 332:1519-1523
-
(2011)
Science
, vol.332
, pp. 1519-1523
-
-
Cohen, J.C.1
Horton, J.D.2
Hobbs, H.H.3
-
55
-
-
33644850802
-
Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: Possible role in steatosis
-
1:CAS:528:DC%2BD28XhsFKht7w%3D 16407588
-
Bradbury MW (2006) Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis. Am J Physiol Gastrointest Liver Physiol 290:G194-G198
-
(2006)
Am J Physiol Gastrointest Liver Physiol
, vol.290
, pp. G194-G198
-
-
Bradbury, M.W.1
-
56
-
-
57649214103
-
Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)
-
1:CAS:528:DC%2BD1cXhsFagu7%2FO 18824034
-
Musso G, Gambino R, Cassader M (2009) Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res 48:1-26
-
(2009)
Prog Lipid Res
, vol.48
, pp. 1-26
-
-
Musso, G.1
Gambino, R.2
Cassader, M.3
-
57
-
-
84934970451
-
Hepatic steatosis as a marker of metabolic dysfunction
-
1:CAS:528:DC%2BC2MXhvFSqtrjO 26102213 4488828
-
Fabbrini E, Magkos F (2015) Hepatic steatosis as a marker of metabolic dysfunction. Nutrients 7:4995-5019
-
(2015)
Nutrients
, vol.7
, pp. 4995-5019
-
-
Fabbrini, E.1
Magkos, F.2
-
58
-
-
0033995287
-
Relationship between carbohydrate-induced hypertriglyceridemia and fatty acid synthesis in lean and obese subjects
-
1:CAS:528:DC%2BD3cXjt1Chtrk%3D 10744780
-
Hudgins LC, Hellerstein MK, Seidman CE, Neese RA, Tremaroli JD, Hirsch J (2000) Relationship between carbohydrate-induced hypertriglyceridemia and fatty acid synthesis in lean and obese subjects. J Lipid Res 41:595-604
-
(2000)
J Lipid Res
, vol.41
, pp. 595-604
-
-
Hudgins, L.C.1
Hellerstein, M.K.2
Seidman, C.E.3
Neese, R.A.4
Tremaroli, J.D.5
Hirsch, J.6
-
59
-
-
0036089126
-
Dietary carbohydrate's effects on lipogenesis and the relationship of lipogenesis to blood insulin and glucose concentrations
-
1:CAS:528:DC%2BD38XkvVCisb0%3D 12088525
-
Parks EJ (2002) Dietary carbohydrate's effects on lipogenesis and the relationship of lipogenesis to blood insulin and glucose concentrations. Br J Nutr 87(Suppl 2):S247-S253
-
(2002)
Br J Nutr
, vol.87
, pp. S247-S253
-
-
Parks, E.J.1
-
60
-
-
0031887281
-
Role of human liver lipogenesis and reesterification in triglycerides secretion and in FFA reesterification
-
1:CAS:528:DyaK1cXis1yqtr0%3D 9486165
-
Diraison F, Beylot M (1998) Role of human liver lipogenesis and reesterification in triglycerides secretion and in FFA reesterification. Am J Physiol 274:E321-E327
-
(1998)
Am J Physiol
, vol.274
, pp. E321-E327
-
-
Diraison, F.1
Beylot, M.2
-
61
-
-
0035084699
-
Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
-
1:CAS:528:DC%2BD3MXjtVeqsb8%3D 11266382
-
Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN (2001) Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120:1183-1192
-
(2001)
Gastroenterology
, vol.120
, pp. 1183-1192
-
-
Sanyal, A.J.1
Campbell-Sargent, C.2
Mirshahi, F.3
Rizzo, W.B.4
Contos, M.J.5
Sterling, R.K.6
Luketic, V.A.7
Shiffman, M.L.8
Clore, J.N.9
-
62
-
-
0142245750
-
Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test
-
14572600
-
Miele L, Grieco A, Armuzzi A, Candelli M, Forgione A, Gasbarrini A, Gasbarrini G (2003) Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. Am J Gastroenterol 98:2335-2336
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 2335-2336
-
-
Miele, L.1
Grieco, A.2
Armuzzi, A.3
Candelli, M.4
Forgione, A.5
Gasbarrini, A.6
Gasbarrini, G.7
-
63
-
-
39149104311
-
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis
-
1:CAS:528:DC%2BD1cXitVGltL0%3D 18218340
-
Marra F, Gastaldelli A, Svegliati Baroni G, Tell G, Tiribelli C (2008) Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol Med 14:72-81
-
(2008)
Trends Mol Med
, vol.14
, pp. 72-81
-
-
Marra, F.1
Gastaldelli, A.2
Svegliati Baroni, G.3
Tell, G.4
Tiribelli, C.5
-
64
-
-
0035658444
-
Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis
-
1:CAS:528:DC%2BD3MXptlKmtLw%3D 11705737
-
Reddy JK (2001) Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis. Am J Physiol Gastrointest Liver Physiol 281:G1333-G1339
-
(2001)
Am J Physiol Gastrointest Liver Physiol
, vol.281
, pp. G1333-G1339
-
-
Reddy, J.K.1
-
65
-
-
0036780582
-
Pathogenesis of steatohepatitis
-
1:CAS:528:DC%2BD3sXkvFKgs7c%3D 12406438
-
Day CP (2002) Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol 16:663-678
-
(2002)
Best Pract Res Clin Gastroenterol
, vol.16
, pp. 663-678
-
-
Day, C.P.1
-
66
-
-
38649111018
-
Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease
-
1:CAS:528:DC%2BD1cXivFKqurg%3D 18242210 2705923
-
Fabbrini E, Mohammed BS, Magkos F, Korenblat KM, Patterson BW, Klein S (2008) Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 134:424-431
-
(2008)
Gastroenterology
, vol.134
, pp. 424-431
-
-
Fabbrini, E.1
Mohammed, B.S.2
Magkos, F.3
Korenblat, K.M.4
Patterson, B.W.5
Klein, S.6
-
67
-
-
33644827082
-
Overproduction of large VLDL particles is driven by increased liver fat content in man
-
1:CAS:528:DC%2BD28XitF2jsbg%3D 16463046
-
Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, Vehkavaara S, Hakkinen A, Olofsson SO, Yki-Jarvinen H, Boren J (2006) Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 49:755-765
-
(2006)
Diabetologia
, vol.49
, pp. 755-765
-
-
Adiels, M.1
Taskinen, M.R.2
Packard, C.3
Caslake, M.J.4
Soro-Paavonen, A.5
Westerbacka, J.6
Vehkavaara, S.7
Hakkinen, A.8
Olofsson, S.O.9
Yki-Jarvinen, H.10
Boren, J.11
-
68
-
-
30944469306
-
Adipokines in NASH: Postprandial lipid metabolism as a link between adiponectin and liver disease
-
1:CAS:528:DC%2BD2MXht1amtbvE 16231364
-
Musso G, Gambino R, Durazzo M, Biroli G, Carello M, Faga E, Pacini G, De Michieli F, Rabbione L, Premoli A, Cassader M, Pagano G (2005) Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology 42:1175-1183
-
(2005)
Hepatology
, vol.42
, pp. 1175-1183
-
-
Musso, G.1
Gambino, R.2
Durazzo, M.3
Biroli, G.4
Carello, M.5
Faga, E.6
Pacini, G.7
De Michieli, F.8
Rabbione, L.9
Premoli, A.10
Cassader, M.11
Pagano, G.12
-
69
-
-
79959336013
-
Lipid in the livers of adolescents with nonalcoholic steatohepatitis: Combined effects of pathways on steatosis
-
1:CAS:528:DC%2BC3MXnslKmsb8%3D 21075404
-
Zhu L, Baker SS, Liu W, Tao MH, Patel R, Nowak NJ, Baker RD (2011) Lipid in the livers of adolescents with nonalcoholic steatohepatitis: combined effects of pathways on steatosis. Metabolism 60:1001-1011
-
(2011)
Metabolism
, vol.60
, pp. 1001-1011
-
-
Zhu, L.1
Baker, S.S.2
Liu, W.3
Tao, M.H.4
Patel, R.5
Nowak, N.J.6
Baker, R.D.7
-
70
-
-
70349249503
-
Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis
-
1:CAS:528:DC%2BD1MXhtFKntL%2FO 19650159
-
Fujita K, Nozaki Y, Wada K, Yoneda M, Fujimoto Y, Fujitake M, Endo H, Takahashi H, Inamori M, Kobayashi N, Kirikoshi H, Kubota K, Saito S, Nakajima A (2009) Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis. Hepatology 50:772-780
-
(2009)
Hepatology
, vol.50
, pp. 772-780
-
-
Fujita, K.1
Nozaki, Y.2
Wada, K.3
Yoneda, M.4
Fujimoto, Y.5
Fujitake, M.6
Endo, H.7
Takahashi, H.8
Inamori, M.9
Kobayashi, N.10
Kirikoshi, H.11
Kubota, K.12
Saito, S.13
Nakajima, A.14
-
71
-
-
38649116056
-
Selective versus total insulin resistance: A pathogenic paradox
-
1:CAS:528:DC%2BD1cXitVWhtro%3D 18249166
-
Brown MS, Goldstein JL (2008) Selective versus total insulin resistance: a pathogenic paradox. Cell Metab 7:95-96
-
(2008)
Cell Metab
, vol.7
, pp. 95-96
-
-
Brown, M.S.1
Goldstein, J.L.2
-
72
-
-
20944450486
-
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: Sites and mechanisms
-
1:CAS:528:DC%2BD2MXjtlGhs7w%3D 15747110
-
Bugianesi E, Gastaldelli A, Vanni E, Gambino R, Cassader M, Baldi S, Ponti V, Pagano G, Ferrannini E, Rizzetto M (2005) Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 48:634-642
-
(2005)
Diabetologia
, vol.48
, pp. 634-642
-
-
Bugianesi, E.1
Gastaldelli, A.2
Vanni, E.3
Gambino, R.4
Cassader, M.5
Baldi, S.6
Ponti, V.7
Pagano, G.8
Ferrannini, E.9
Rizzetto, M.10
-
73
-
-
70349326750
-
Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
-
1:CAS:528:DC%2BD1MXhtFGgtrzF 19706383 2741268
-
Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, Okunade A, Klein S (2009) Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA 106:15430-15435
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 15430-15435
-
-
Fabbrini, E.1
Magkos, F.2
Mohammed, B.S.3
Pietka, T.4
Abumrad, N.A.5
Patterson, B.W.6
Okunade, A.7
Klein, S.8
-
74
-
-
42949178538
-
Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects
-
1:CAS:528:DC%2BD1cXntVWhtbo%3D 18355813 2629391
-
Korenblat KM, Fabbrini E, Mohammed BS, Klein S (2008) Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 134:1369-1375
-
(2008)
Gastroenterology
, vol.134
, pp. 1369-1375
-
-
Korenblat, K.M.1
Fabbrini, E.2
Mohammed, B.S.3
Klein, S.4
-
75
-
-
0036312905
-
Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men
-
1:CAS:528:DC%2BD38XlsVGjsbs%3D 12107194
-
Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, Goto T, Westerbacka J, Sovijarvi A, Halavaara J, Yki-Jarvinen H (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87:3023-3028
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 3023-3028
-
-
Seppala-Lindroos, A.1
Vehkavaara, S.2
Hakkinen, A.M.3
Goto, T.4
Westerbacka, J.5
Sovijarvi, A.6
Halavaara, J.7
Yki-Jarvinen, H.8
-
76
-
-
84939139499
-
Does diacylglycerol accumulation in fatty liver disease cause hepatic insulin resistance?
-
26273583 4529893
-
Finck BN, Hall AM (2015) Does diacylglycerol accumulation in fatty liver disease cause hepatic insulin resistance? Biomed Res Int 2015:104132
-
(2015)
Biomed Res Int
, vol.2015
, pp. 104132
-
-
Finck, B.N.1
Hall, A.M.2
-
77
-
-
84884860377
-
Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes
-
23929732 3946772
-
Birkenfeld AL, Shulman GI (2014) Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology 59:713-723
-
(2014)
Hepatology
, vol.59
, pp. 713-723
-
-
Birkenfeld, A.L.1
Shulman, G.I.2
-
78
-
-
84872671526
-
Liver and diabetes. A vicious circle
-
1:CAS:528:DC%2BC3sXjsVKlt7g%3D 23332087 3733501
-
Loria P, Lonardo A, Anania F (2013) Liver and diabetes. A vicious circle. Hepatol Res 43:51-64
-
(2013)
Hepatol Res
, vol.43
, pp. 51-64
-
-
Loria, P.1
Lonardo, A.2
Anania, F.3
-
79
-
-
84901944641
-
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
-
1:CAS:528:DC%2BC2cXhtFygs7zN 24899308 4489847
-
Perry RJ, Samuel VT, Petersen KF, Shulman GI (2014) The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature 510:84-91
-
(2014)
Nature
, vol.510
, pp. 84-91
-
-
Perry, R.J.1
Samuel, V.T.2
Petersen, K.F.3
Shulman, G.I.4
-
80
-
-
84867913712
-
Fatty liver as a consequence and cause of insulin resistance: Lessons from type 2 diabetic liver
-
1:CAS:528:DC%2BC3sXhslWgs70%3D 22893453
-
Takamura T, Misu H, Ota T, Kaneko S (2012) Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver. Endocr J 59:745-763
-
(2012)
Endocr J
, vol.59
, pp. 745-763
-
-
Takamura, T.1
Misu, H.2
Ota, T.3
Kaneko, S.4
-
81
-
-
84874741669
-
Diabetes and nonalcoholic fatty liver disease: A pathogenic duo
-
1:CAS:528:DC%2BC3sXjs1Ors7w%3D 23238855
-
Williams KH, Shackel NA, Gorrell MD, McLennan SV, Twigg SM (2013) Diabetes and nonalcoholic fatty liver disease: a pathogenic duo. Endocr Rev 34:84-129
-
(2013)
Endocr Rev
, vol.34
, pp. 84-129
-
-
Williams, K.H.1
Shackel, N.A.2
Gorrell, M.D.3
McLennan, S.V.4
Twigg, S.M.5
-
82
-
-
2142762456
-
Fatty liver in familial hypobetalipoproteinemia: Roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity
-
1:CAS:528:DC%2BD2cXjsFKis7Y%3D 14967820
-
Tanoli T, Yue P, Yablonskiy D, Schonfeld G (2004) Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity. J Lipid Res 45:941-947
-
(2004)
J Lipid Res
, vol.45
, pp. 941-947
-
-
Tanoli, T.1
Yue, P.2
Yablonskiy, D.3
Schonfeld, G.4
-
83
-
-
65949095803
-
Autophagy regulates lipid metabolism
-
1:CAS:528:DC%2BD1MXjvV2ks7s%3D 19339967 2676208
-
Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, Tanaka K, Cuervo AM, Czaja MJ (2009) Autophagy regulates lipid metabolism. Nature 458:1131-1135
-
(2009)
Nature
, vol.458
, pp. 1131-1135
-
-
Singh, R.1
Kaushik, S.2
Wang, Y.3
Xiang, Y.4
Novak, I.5
Komatsu, M.6
Tanaka, K.7
Cuervo, A.M.8
Czaja, M.J.9
-
84
-
-
77956400005
-
Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance
-
1:CAS:528:DC%2BC3cXnsFyitrs%3D 20519119 2881480
-
Yang L, Li P, Fu S, Calay ES, Hotamisligil GS (2010) Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab 11:467-478
-
(2010)
Cell Metab
, vol.11
, pp. 467-478
-
-
Yang, L.1
Li, P.2
Fu, S.3
Calay, E.S.4
Hotamisligil, G.S.5
-
85
-
-
84952927680
-
Protective role of autophagy in methionine-choline deficient diet-induced advanced nonalcoholic steatohepatitis in mice
-
1:CAS:528:DC%2BC2MXhvFCltr%2FE 26593434
-
Chen R, Wang Q, Song S, Liu F, He B, Gao X (2016) Protective role of autophagy in methionine-choline deficient diet-induced advanced nonalcoholic steatohepatitis in mice. Eur J Pharmacol 770:126-133
-
(2016)
Eur J Pharmacol
, vol.770
, pp. 126-133
-
-
Chen, R.1
Wang, Q.2
Song, S.3
Liu, F.4
He, B.5
Gao, X.6
-
86
-
-
84903903918
-
Immunohistochemical study of the autophagy marker microtubule-associated protein 1 light chain 3 in normal and steatotic human livers
-
1:CAS:528:DC%2BC2cXhtFajt7vJ 23773367
-
Kashima J, Shintani-Ishida K, Nakajima M, Maeda H, Unuma K, Uchiyama Y, Yoshida K (2014) Immunohistochemical study of the autophagy marker microtubule-associated protein 1 light chain 3 in normal and steatotic human livers. Hepatol Res 44:779-787
-
(2014)
Hepatol Res
, vol.44
, pp. 779-787
-
-
Kashima, J.1
Shintani-Ishida, K.2
Nakajima, M.3
Maeda, H.4
Unuma, K.5
Uchiyama, Y.6
Yoshida, K.7
-
87
-
-
84907881796
-
Abnormality of autophagic function and cathepsin expression in the liver from patients with non-alcoholic fatty liver disease
-
1:CAS:528:DC%2BC2cXhsFyjurfK 24299564
-
Fukuo Y, Yamashina S, Sonoue H, Arakawa A, Nakadera E, Aoyama T, Uchiyama A, Kon K, Ikejima K, Watanabe S (2014) Abnormality of autophagic function and cathepsin expression in the liver from patients with non-alcoholic fatty liver disease. Hepatol Res 44:1026-1036
-
(2014)
Hepatol Res
, vol.44
, pp. 1026-1036
-
-
Fukuo, Y.1
Yamashina, S.2
Sonoue, H.3
Arakawa, A.4
Nakadera, E.5
Aoyama, T.6
Uchiyama, A.7
Kon, K.8
Ikejima, K.9
Watanabe, S.10
-
88
-
-
71449091240
-
Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: Inhibition of FoxO1-dependent expression of key autophagy genes by insulin
-
1:CAS:528:DC%2BD1MXhtlCjsrzO 19758991 2781544
-
Liu HY, Han J, Cao SY, Hong T, Zhuo D, Shi J, Liu Z, Cao W (2009) Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: inhibition of FoxO1-dependent expression of key autophagy genes by insulin. J Biol Chem 284:31484-31492
-
(2009)
J Biol Chem
, vol.284
, pp. 31484-31492
-
-
Liu, H.Y.1
Han, J.2
Cao, S.Y.3
Hong, T.4
Zhuo, D.5
Shi, J.6
Liu, Z.7
Cao, W.8
-
89
-
-
77957302090
-
Hepatic steatosis: A role for de novo lipogenesis and the transcription factor SREBP-1c
-
1:CAS:528:DC%2BC3cXhsVGgs7jJ 21029304
-
Ferre P, Foufelle F (2010) Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab 12(Suppl 2):83-92
-
(2010)
Diabetes Obes Metab
, vol.12
, pp. 83-92
-
-
Ferre, P.1
Foufelle, F.2
-
90
-
-
84904395679
-
Proteomic and genomic studies of non-alcoholic fatty liver disease - Clues in the pathogenesis
-
1:CAS:528:DC%2BC2cXhs12ksL7I 25024592 4093687
-
Lim JW, Dillon J, Miller M (2014) Proteomic and genomic studies of non-alcoholic fatty liver disease - clues in the pathogenesis. World J Gastroenterol 20:8325-8340
-
(2014)
World J Gastroenterol
, vol.20
, pp. 8325-8340
-
-
Lim, J.W.1
Dillon, J.2
Miller, M.3
-
91
-
-
77953766314
-
Non-alcoholic fatty liver disease proteomics
-
1:CAS:528:DC%2BC3cXktFyruro%3D 21137056 3040121
-
Rodriguez-Suarez E, Duce AM, Caballeria J, Martinez Arrieta F, Fernandez E, Gomara C, Alkorta N, Ariz U, Martinez-Chantar ML, Lu SC, Elortza F, Mato JM (2010) Non-alcoholic fatty liver disease proteomics. Proteomics Clin Appl 4:362-371
-
(2010)
Proteomics Clin Appl
, vol.4
, pp. 362-371
-
-
Rodriguez-Suarez, E.1
Duce, A.M.2
Caballeria, J.3
Martinez Arrieta, F.4
Fernandez, E.5
Gomara, C.6
Alkorta, N.7
Ariz, U.8
Martinez-Chantar, M.L.9
Lu, S.C.10
Elortza, F.11
Mato, J.M.12
-
92
-
-
84937882413
-
The role of PDE3B phosphorylation in the inhibition of lipolysis by insulin
-
1:CAS:528:DC%2BC2MXht12qt7nP 26031333 4508315
-
DiPilato LM, Ahmad F, Harms M, Seale P, Manganiello V, Birnbaum MJ (2015) The role of PDE3B phosphorylation in the inhibition of lipolysis by insulin. Mol Cell Biol 35:2752-2760
-
(2015)
Mol Cell Biol
, vol.35
, pp. 2752-2760
-
-
DiPilato, L.M.1
Ahmad, F.2
Harms, M.3
Seale, P.4
Manganiello, V.5
Birnbaum, M.J.6
-
93
-
-
84883548896
-
Insulin inhibits lipolysis in adipocytes via the evolutionarily conserved mTORC1-Egr1-ATGL-mediated pathway
-
1:CAS:528:DC%2BC3sXhtl2jsrrP 23858058 3753874
-
Chakrabarti P, Kim JY, Singh M, Shin YK, Kim J, Kumbrink J, Wu Y, Lee MJ, Kirsch KH, Fried SK, Kandror KV (2013) Insulin inhibits lipolysis in adipocytes via the evolutionarily conserved mTORC1-Egr1-ATGL-mediated pathway. Mol Cell Biol 33:3659-3666
-
(2013)
Mol Cell Biol
, vol.33
, pp. 3659-3666
-
-
Chakrabarti, P.1
Kim, J.Y.2
Singh, M.3
Shin, Y.K.4
Kim, J.5
Kumbrink, J.6
Wu, Y.7
Lee, M.J.8
Kirsch, K.H.9
Fried, S.K.10
Kandror, K.V.11
-
94
-
-
77951166692
-
Mammalian target of rapamycin complex 1 suppresses lipolysis, stimulates lipogenesis, and promotes fat storage
-
1:CAS:528:DC%2BC3cXltFSmsbg%3D 20068142 2844824
-
Chakrabarti P, English T, Shi J, Smas CM, Kandror KV (2010) Mammalian target of rapamycin complex 1 suppresses lipolysis, stimulates lipogenesis, and promotes fat storage. Diabetes 59:775-781
-
(2010)
Diabetes
, vol.59
, pp. 775-781
-
-
Chakrabarti, P.1
English, T.2
Shi, J.3
Smas, C.M.4
Kandror, K.V.5
-
95
-
-
79961002859
-
Adipose triglyceride lipase: A new target in the regulation of lipolysis by insulin
-
1:CAS:528:DC%2BC3MXhtFOis7rJ 21644917
-
Chakrabarti P, Kandror KV (2011) Adipose triglyceride lipase: a new target in the regulation of lipolysis by insulin. Curr Diabetes Rev 7:270-277
-
(2011)
Curr Diabetes Rev
, vol.7
, pp. 270-277
-
-
Chakrabarti, P.1
Kandror, K.V.2
-
96
-
-
78449300149
-
Obesity and insulin resistance-related changes in the expression of lipogenic and lipolytic genes in morbidly obese subjects
-
1:STN:280:DC%2BC3cfnsFKmsQ%3D%3D 20512427
-
Tinahones FJ, Garrido-Sanchez L, Miranda M, Garcia-Almeida JM, Macias-Gonzalez M, Ceperuelo V, Gluckmann E, Rivas-Marin J, Vendrell J, Garcia-Fuentes E (2010) Obesity and insulin resistance-related changes in the expression of lipogenic and lipolytic genes in morbidly obese subjects. Obes Surg 20:1559-1567
-
(2010)
Obes Surg
, vol.20
, pp. 1559-1567
-
-
Tinahones, F.J.1
Garrido-Sanchez, L.2
Miranda, M.3
Garcia-Almeida, J.M.4
Macias-Gonzalez, M.5
Ceperuelo, V.6
Gluckmann, E.7
Rivas-Marin, J.8
Vendrell, J.9
Garcia-Fuentes, E.10
-
97
-
-
77950233673
-
A fresh look at NASH pathogenesis. Part 1: The metabolic movers
-
1:CAS:528:DC%2BC3cXmsVSqs7w%3D 20492324
-
Larter CZ, Chitturi S, Heydet D, Farrell GC (2010) A fresh look at NASH pathogenesis. Part 1: the metabolic movers. J Gastroenterol Hepatol 25:672-690
-
(2010)
J Gastroenterol Hepatol
, vol.25
, pp. 672-690
-
-
Larter, C.Z.1
Chitturi, S.2
Heydet, D.3
Farrell, G.C.4
-
98
-
-
84864090834
-
Mechanisms of simple hepatic steatosis: Not so simple after all
-
22824478
-
Matherly SC, Puri P (2012) Mechanisms of simple hepatic steatosis: not so simple after all. Clin Liver Dis 16:505-524
-
(2012)
Clin Liver Dis
, vol.16
, pp. 505-524
-
-
Matherly, S.C.1
Puri, P.2
-
99
-
-
0037148928
-
Leptin-replacement therapy for lipodystrophy
-
1:CAS:528:DC%2BD38XhsFKqu7c%3D 11856796
-
Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, Wagner AJ, DePaoli AM, Reitman ML, Taylor SI, Gorden P, Garg A (2002) Leptin-replacement therapy for lipodystrophy. N Engl J Med 346:570-578
-
(2002)
N Engl J Med
, vol.346
, pp. 570-578
-
-
Oral, E.A.1
Simha, V.2
Ruiz, E.3
Andewelt, A.4
Premkumar, A.5
Snell, P.6
Wagner, A.J.7
DePaoli, A.M.8
Reitman, M.L.9
Taylor, S.I.10
Gorden, P.11
Garg, A.12
-
100
-
-
8144226856
-
The gut microbiota as an environmental factor that regulates fat storage
-
15505215 524219
-
Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101:15718-15723
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 15718-15723
-
-
Backhed, F.1
Ding, H.2
Wang, T.3
Hooper, L.V.4
Koh, G.Y.5
Nagy, A.6
Semenkovich, C.F.7
Gordon, J.I.8
-
101
-
-
84919385811
-
The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease
-
1:CAS:528:DC%2BC2MXisFSjsr4%3D 25479248 4276985
-
Ferolla SM, Armiliato GN, Couto CA, Ferrari TC (2014) The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease. Nutrients 6:5583-5599
-
(2014)
Nutrients
, vol.6
, pp. 5583-5599
-
-
Ferolla, S.M.1
Armiliato, G.N.2
Couto, C.A.3
Ferrari, T.C.4
-
102
-
-
84905717052
-
Mechanisms of liver injury in non-alcoholic steatohepatitis
-
25045618 4097318
-
Duwaerts CC, Maher JJ (2014) Mechanisms of liver injury in non-alcoholic steatohepatitis. Curr Hepatol Rep 13:119-129
-
(2014)
Curr Hepatol Rep
, vol.13
, pp. 119-129
-
-
Duwaerts, C.C.1
Maher, J.J.2
-
103
-
-
80053618114
-
Linking long-term dietary patterns with gut microbial enterotypes
-
1:CAS:528:DC%2BC3MXht1Gms77K 21885731 3368382
-
Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, Sinha R, Gilroy E, Gupta K, Baldassano R, Nessel L, Li H, Bushman FD, Lewis JD (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science 334:105-108
-
(2011)
Science
, vol.334
, pp. 105-108
-
-
Wu, G.D.1
Chen, J.2
Hoffmann, C.3
Bittinger, K.4
Chen, Y.Y.5
Keilbaugh, S.A.6
Bewtra, M.7
Knights, D.8
Walters, W.A.9
Knight, R.10
Sinha, R.11
Gilroy, E.12
Gupta, K.13
Baldassano, R.14
Nessel, L.15
Li, H.16
Bushman, F.D.17
Lewis, J.D.18
-
104
-
-
84920621136
-
Gut microbiome and nonalcoholic fatty liver diseases
-
1:CAS:528:DC%2BC2MXmslOrtQ%3D%3D 25310763
-
Zhu L, Baker RD, Baker SS (2015) Gut microbiome and nonalcoholic fatty liver diseases. Pediatr Res 77:245-251
-
(2015)
Pediatr Res
, vol.77
, pp. 245-251
-
-
Zhu, L.1
Baker, R.D.2
Baker, S.S.3
-
105
-
-
84873296091
-
Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH
-
1:CAS:528:DC%2BC3sXit1Wgsbo%3D 23055155
-
Zhu L, Baker SS, Gill C, Liu W, Alkhouri R, Baker RD, Gill SR (2013) Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 57:601-609
-
(2013)
Hepatology
, vol.57
, pp. 601-609
-
-
Zhu, L.1
Baker, S.S.2
Gill, C.3
Liu, W.4
Alkhouri, R.5
Baker, R.D.6
Gill, S.R.7
-
106
-
-
84920401295
-
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
-
25500885 4382255
-
Jiang C, Xie C, Li F, Zhang L, Nichols RG, Krausz KW, Cai J, Qi Y, Fang ZZ, Takahashi S, Tanaka N, Desai D, Amin SG, Albert I, Patterson AD, Gonzalez FJ (2015) Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease. J Clin Invest 125:386-402
-
(2015)
J Clin Invest
, vol.125
, pp. 386-402
-
-
Jiang, C.1
Xie, C.2
Li, F.3
Zhang, L.4
Nichols, R.G.5
Krausz, K.W.6
Cai, J.7
Qi, Y.8
Fang, Z.Z.9
Takahashi, S.10
Tanaka, N.11
Desai, D.12
Amin, S.G.13
Albert, I.14
Patterson, A.D.15
Gonzalez, F.J.16
-
107
-
-
68249110221
-
The role of pH in determining the species composition of the human colonic microbiota
-
19397676
-
Duncan SH, Louis P, Thomson JM, Flint HJ (2009) The role of pH in determining the species composition of the human colonic microbiota. Environ Microbiol 11:2112-2122
-
(2009)
Environ Microbiol
, vol.11
, pp. 2112-2122
-
-
Duncan, S.H.1
Louis, P.2
Thomson, J.M.3
Flint, H.J.4
-
108
-
-
0020710588
-
Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats
-
1:STN:280:DyaL3s7msFelsw%3D%3D 6834773
-
Wostmann BS, Larkin C, Moriarty A, Bruckner-Kardoss E (1983) Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats. Lab Anim Sci 33:46-50
-
(1983)
Lab Anim Sci
, vol.33
, pp. 46-50
-
-
Wostmann, B.S.1
Larkin, C.2
Moriarty, A.3
Bruckner-Kardoss, E.4
-
109
-
-
73949137604
-
Microbiota and SCFA in lean and overweight healthy subjects
-
Schwiertz A, Taras D, Schafer K, Beijer S, Bos NA, Donus C, Hardt PD (2010) Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 18:190-195
-
(2010)
Obesity (Silver Spring)
, vol.18
, pp. 190-195
-
-
Schwiertz, A.1
Taras, D.2
Schafer, K.3
Beijer, S.4
Bos, N.A.5
Donus, C.6
Hardt, P.D.7
-
110
-
-
84865477413
-
Antibiotics in early life alter the murine colonic microbiome and adiposity
-
1:CAS:528:DC%2BC38Xht1Ghtr%2FM 22914093 3553221
-
Cho I, Yamanishi S, Cox L, Methe BA, Zavadil J, Li K, Gao Z, Mahana D, Raju K, Teitler I, Li H, Alekseyenko AV, Blaser MJ (2012) Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488:621-626
-
(2012)
Nature
, vol.488
, pp. 621-626
-
-
Cho, I.1
Yamanishi, S.2
Cox, L.3
Methe, B.A.4
Zavadil, J.5
Li, K.6
Gao, Z.7
Mahana, D.8
Raju, K.9
Teitler, I.10
Li, H.11
Alekseyenko, A.V.12
Blaser, M.J.13
-
111
-
-
84886298620
-
Non-alcoholic steatohepatitis: A microbiota-driven disease
-
1:CAS:528:DC%2BC3sXhtVCgtLvE 23827477
-
Moschen AR, Kaser S, Tilg H (2013) Non-alcoholic steatohepatitis: a microbiota-driven disease. Trends Endocrinol Metab 24:537-545
-
(2013)
Trends Endocrinol Metab
, vol.24
, pp. 537-545
-
-
Moschen, A.R.1
Kaser, S.2
Tilg, H.3
-
112
-
-
84925042878
-
The short-chain fatty acid uptake fluxes by mice on a guar gum supplemented diet associate with amelioration of major biomarkers of the metabolic syndrome
-
den Besten G, Havinga R, Bleeker A, Rao S, Gerding A, van Eunen K, Groen AK, Reijngoud DJ, Bakker BM (2014) The short-chain fatty acid uptake fluxes by mice on a guar gum supplemented diet associate with amelioration of major biomarkers of the metabolic syndrome. PLoS One 9:e107392
-
(2014)
PLoS One
, vol.9
, pp. e107392
-
-
Den Besten, G.1
Havinga, R.2
Bleeker, A.3
Rao, S.4
Gerding, A.5
Van Eunen, K.6
Groen, A.K.7
Reijngoud, D.J.8
Bakker, B.M.9
-
113
-
-
84942892391
-
Protection against the metabolic syndrome by guar gum-derived short-chain fatty acids depends on peroxisome proliferator-activated receptor gamma and glucagon-like peptide-1
-
den Besten G, Gerding A, van Dijk TH, Ciapaite J, Bleeker A, van Eunen K, Havinga R, Groen AK, Reijngoud DJ, Bakker BM (2015) Protection against the metabolic syndrome by guar gum-derived short-chain fatty acids depends on peroxisome proliferator-activated receptor gamma and glucagon-like peptide-1. PLoS One 10:e0136364
-
(2015)
PLoS One
, vol.10
, pp. e0136364
-
-
Den Besten, G.1
Gerding, A.2
Van Dijk, T.H.3
Ciapaite, J.4
Bleeker, A.5
Van Eunen, K.6
Havinga, R.7
Groen, A.K.8
Reijngoud, D.J.9
Bakker, B.M.10
-
114
-
-
84962129359
-
Short-chain fatty acids protect against high-fat diet-induced obesity via a PPARgamma-dependent switch from lipogenesis to fat oxidation
-
den Besten G, Bleeker A, Gerding A, van Eunen K, Havinga R, van Dijk TH, Oosterveer MH, Jonker JW, Groen AK, Reijngoud DJ, Bakker BM (2015) Short-chain fatty acids protect against high-fat diet-induced obesity via a PPARgamma-dependent switch from lipogenesis to fat oxidation. Diabetes 64:2398-2408
-
(2015)
Diabetes
, vol.64
, pp. 2398-2408
-
-
Den Besten, G.1
Bleeker, A.2
Gerding, A.3
Van Eunen, K.4
Havinga, R.5
Van Dijk, T.H.6
Oosterveer, M.H.7
Jonker, J.W.8
Groen, A.K.9
Reijngoud, D.J.10
Bakker, B.M.11
-
115
-
-
0015236260
-
Observations of the formation of ethanol in the intestinal tract in man
-
1:STN:280:DyaE3M3jslyrug%3D%3D 5556166
-
Blomstrand R (1971) Observations of the formation of ethanol in the intestinal tract in man. Life Sci II 10:575-582
-
(1971)
Life Sci II
, vol.10
, pp. 575-582
-
-
Blomstrand, R.1
-
116
-
-
29044438428
-
The formation of ethanol in Escherichia coli
-
1:CAS:528:DyaG2sXhtlGrsw%3D%3D 13382840
-
Dawes EA, Foster SM (1956) The formation of ethanol in Escherichia coli. Biochim Biophys Acta 22:253-265
-
(1956)
Biochim Biophys Acta
, vol.22
, pp. 253-265
-
-
Dawes, E.A.1
Foster, S.M.2
-
117
-
-
84864193026
-
Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD)
-
1:CAS:528:DC%2BC38XpsFajtrw%3D 22427130
-
Volynets V, Kuper MA, Strahl S, Maier IB, Spruss A, Wagnerberger S, Konigsrainer A, Bischoff SC, Bergheim I (2012) Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD). Dig Dis Sci 57:1932-1941
-
(2012)
Dig Dis Sci
, vol.57
, pp. 1932-1941
-
-
Volynets, V.1
Kuper, M.A.2
Strahl, S.3
Maier, I.B.4
Spruss, A.5
Wagnerberger, S.6
Konigsrainer, A.7
Bischoff, S.C.8
Bergheim, I.9
-
118
-
-
72949130825
-
Anaerobic dissimilation of glucose-C14 by Escherichia coli
-
1:CAS:528:DyaF3MXkvFenuw%3D%3D 13731991 278961
-
Paege LM, Gibbs M (1961) Anaerobic dissimilation of glucose-C14 by Escherichia coli. J Bacteriol 81:107-110
-
(1961)
J Bacteriol
, vol.81
, pp. 107-110
-
-
Paege, L.M.1
Gibbs, M.2
-
119
-
-
0024723183
-
The fermentation pathways of Escherichia coli
-
1:STN:280:DyaK3c7pvVGhtg%3D%3D 2698228
-
Clark DP (1989) The fermentation pathways of Escherichia coli. FEMS Microbiol Rev 5:223-234
-
(1989)
FEMS Microbiol Rev
, vol.5
, pp. 223-234
-
-
Clark, D.P.1
-
120
-
-
0021965569
-
Studies of metabolites in diarrheal stool specimens containing Shigella species by frequency-pulsed electron capture gas-liquid chromatography
-
1:CAS:528:DyaL2MXitFOlu74%3D 3886695 271728
-
Brooks JB, Basta MT, el Kholy AM (1985) Studies of metabolites in diarrheal stool specimens containing Shigella species by frequency-pulsed electron capture gas-liquid chromatography. J Clin Microbiol 21:599-606
-
(1985)
J Clin Microbiol
, vol.21
, pp. 599-606
-
-
Brooks, J.B.1
Basta, M.T.2
El Kholy, A.M.3
-
121
-
-
84949959656
-
Heritability of hepatic fibrosis and steatosis based on a prospective twin study
-
26299412
-
Loomba R, Schork N, Chen CH, Bettencourt R, Bhatt A, Ang B, Nguyen P, Hernandez C, Richards L, Salotti J, Lin S, Seki E, Nelson KE, Sirlin CB, Brenner D (2015) Heritability of hepatic fibrosis and steatosis based on a prospective twin study. Gastroenterology 149:1784-1793
-
(2015)
Gastroenterology
, vol.149
, pp. 1784-1793
-
-
Loomba, R.1
Schork, N.2
Chen, C.H.3
Bettencourt, R.4
Bhatt, A.5
Ang, B.6
Nguyen, P.7
Hernandez, C.8
Richards, L.9
Salotti, J.10
Lin, S.11
Seki, E.12
Nelson, K.E.13
Sirlin, C.B.14
Brenner, D.15
-
123
-
-
79953745343
-
Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits
-
1:CAS:528:DC%2BC3MXjslKlsL4%3D 21423719 3053321
-
Speliotes EK, Yerges-Armstrong LM, Wu J, Hernaez R, Kim LJ, Palmer CD, Gudnason V, Eiriksdottir G, Garcia ME, Launer LJ, Nalls MA, Clark JM, Mitchell BD, Shuldiner AR, Butler JL, Tomas M, Hoffmann U, Hwang SJ, Massaro JM, O'Donnell CJ, Sahani DV, Salomaa V, Schadt EE, Schwartz SM, Siscovick DS, Voight BF, Carr JJ, Feitosa MF, Harris TB, Fox CS, Smith AV, Kao WH, Hirschhorn JN, Borecki IB (2011) Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet 7:e1001324
-
(2011)
PLoS Genet
, vol.7
, pp. e1001324
-
-
Speliotes, E.K.1
Yerges-Armstrong, L.M.2
Wu, J.3
Hernaez, R.4
Kim, L.J.5
Palmer, C.D.6
Gudnason, V.7
Eiriksdottir, G.8
Garcia, M.E.9
Launer, L.J.10
Nalls, M.A.11
Clark, J.M.12
Mitchell, B.D.13
Shuldiner, A.R.14
Butler, J.L.15
Tomas, M.16
Hoffmann, U.17
Hwang, S.J.18
Massaro, J.M.19
O'Donnell, C.J.20
Sahani, D.V.21
Salomaa, V.22
Schadt, E.E.23
Schwartz, S.M.24
Siscovick, D.S.25
Voight, B.F.26
Carr, J.J.27
Feitosa, M.F.28
Harris, T.B.29
Fox, C.S.30
Smith, A.V.31
Kao, W.H.32
Hirschhorn, J.N.33
Borecki, I.B.34
more..
-
124
-
-
84939200165
-
Genetic factors in the pathogenesis of nonalcoholic fatty liver and steatohepatitis
-
26273621 4530215
-
Dongiovanni P, Romeo S, Valenti L (2015) Genetic factors in the pathogenesis of nonalcoholic fatty liver and steatohepatitis. Biomed Res Int 2015:460190
-
(2015)
Biomed Res Int
, vol.2015
, pp. 460190
-
-
Dongiovanni, P.1
Romeo, S.2
Valenti, L.3
-
125
-
-
56749096610
-
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
-
1:CAS:528:DC%2BD1cXhsVWgsrrP 18820647 2597056
-
Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, Boerwinkle E, Cohen JC, Hobbs HH (2008) Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 40:1461-1465
-
(2008)
Nat Genet
, vol.40
, pp. 1461-1465
-
-
Romeo, S.1
Kozlitina, J.2
Xing, C.3
Pertsemlidis, A.4
Cox, D.5
Pennacchio, L.A.6
Boerwinkle, E.7
Cohen, J.C.8
Hobbs, H.H.9
-
126
-
-
77952785795
-
Non-alcoholic fatty liver disease from pathogenesis to management: An update
-
1:CAS:528:DC%2BC3cXovV2rtLk%3D 19845871
-
Musso G, Gambino R, Cassader M (2010) Non-alcoholic fatty liver disease from pathogenesis to management: an update. Obes Rev 11:430-445
-
(2010)
Obes Rev
, vol.11
, pp. 430-445
-
-
Musso, G.1
Gambino, R.2
Cassader, M.3
-
127
-
-
78751489992
-
Pnpla3/adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome
-
1:CAS:528:DC%2BC3MXht1alurY%3D 21068004 3023552
-
Basantani MK, Sitnick MT, Cai L, Brenner DS, Gardner NP, Li JZ, Schoiswohl G, Yang K, Kumari M, Gross RW, Zechner R, Kershaw EE (2011) Pnpla3/adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome. J Lipid Res 52:318-329
-
(2011)
J Lipid Res
, vol.52
, pp. 318-329
-
-
Basantani, M.K.1
Sitnick, M.T.2
Cai, L.3
Brenner, D.S.4
Gardner, N.P.5
Li, J.Z.6
Schoiswohl, G.7
Yang, K.8
Kumari, M.9
Gross, R.W.10
Zechner, R.11
Kershaw, E.E.12
-
128
-
-
79960729651
-
Mouse patatin-like phospholipase domain-containing 3 influences systemic lipid and glucose homeostasis
-
1:CAS:528:DC%2BC3MXpt1yju7k%3D 21547936
-
Qiao A, Liang J, Ke Y, Li C, Cui Y, Shen L, Zhang H, Cui A, Liu X, Liu C, Chen Y, Zhu Y, Guan Y, Fang F, Chang Y (2011) Mouse patatin-like phospholipase domain-containing 3 influences systemic lipid and glucose homeostasis. Hepatology 54:509-521
-
(2011)
Hepatology
, vol.54
, pp. 509-521
-
-
Qiao, A.1
Liang, J.2
Ke, Y.3
Li, C.4
Cui, Y.5
Shen, L.6
Zhang, H.7
Cui, A.8
Liu, X.9
Liu, C.10
Chen, Y.11
Zhu, Y.12
Guan, Y.13
Fang, F.14
Chang, Y.15
-
129
-
-
84952637318
-
Role of the TM6SF2 rs58542926 in the pathogenesis of non-alcoholic pediatric fatty liver disease (NAFLD): A multiethnic study
-
Goffredo M, Caprio S, Feldstein AE, D'Adamo E, Shaw MM, Pierpont B, Savoye M, Zhao H, Bale AE, Santoro N (2015) Role of the TM6SF2 rs58542926 in the pathogenesis of non-alcoholic pediatric fatty liver disease (NAFLD): a multiethnic study. Hepatology 63(1):117-125. doi: 10.1002/hep.28283
-
(2015)
Hepatology
, vol.63
, Issue.1
, pp. 117-125
-
-
Goffredo, M.1
Caprio, S.2
Feldstein, A.E.3
D'Adamo, E.4
Shaw, M.M.5
Pierpont, B.6
Savoye, M.7
Zhao, H.8
Bale, A.E.9
Santoro, N.10
-
130
-
-
84941885943
-
The genetics of nonalcoholic fatty liver disease: Spotlight on PNPLA3 and TM6SF2
-
1:CAS:528:DC%2BC2MXhsFajtLfM 26378644
-
Anstee QM, Day CP (2015) The genetics of nonalcoholic fatty liver disease: spotlight on PNPLA3 and TM6SF2. Semin Liver Dis 35:270-290
-
(2015)
Semin Liver Dis
, vol.35
, pp. 270-290
-
-
Anstee, Q.M.1
Day, C.P.2
-
132
-
-
77951286204
-
Recent advances in nonalcoholic fatty liver disease
-
20168226
-
Cheung O, Sanyal AJ (2010) Recent advances in nonalcoholic fatty liver disease. Curr Opin Gastroenterol 26:202-208
-
(2010)
Curr Opin Gastroenterol
, vol.26
, pp. 202-208
-
-
Cheung, O.1
Sanyal, A.J.2
-
133
-
-
84887324215
-
Lipotoxicity in the liver
-
24179614 3812457
-
Zambo V, Simon-Szabo L, Szelenyi P, Kereszturi E, Banhegyi G, Csala M (2013) Lipotoxicity in the liver. World J Hepatol 5:550-557
-
(2013)
World J Hepatol
, vol.5
, pp. 550-557
-
-
Zambo, V.1
Simon-Szabo, L.2
Szelenyi, P.3
Kereszturi, E.4
Banhegyi, G.5
Csala, M.6
-
134
-
-
70049089646
-
Lipotoxicity in nonalcoholic fatty liver disease: Not all lipids are created equal
-
1:CAS:528:DC%2BD1MXpvFymtrg%3D 19673631 2775708
-
Alkhouri N, Dixon LJ, Feldstein AE (2009) Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal. Expert Rev Gastroenterol Hepatol 3:445-451
-
(2009)
Expert Rev Gastroenterol Hepatol
, vol.3
, pp. 445-451
-
-
Alkhouri, N.1
Dixon, L.J.2
Feldstein, A.E.3
-
135
-
-
0037453056
-
Triglyceride accumulation protects against fatty acid-induced lipotoxicity
-
1:CAS:528:DC%2BD3sXisVCnsLs%3D 12629214 152249
-
Listenberger LL, Han X, Lewis SE, Cases S, Farese RV Jr, Ory DS, Schaffer JE (2003) Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci USA 100:3077-3082
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 3077-3082
-
-
Listenberger, L.L.1
Han, X.2
Lewis, S.E.3
Cases, S.4
Farese, R.V.5
Ory, D.S.6
Schaffer, J.E.7
-
136
-
-
0035805629
-
Palmitate-induced apoptosis can occur through a ceramide-independent pathway
-
1:CAS:528:DC%2BD3MXjs1Orsro%3D 11278654
-
Listenberger LL, Ory DS, Schaffer JE (2001) Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J Biol Chem 276:14890-14895
-
(2001)
J Biol Chem
, vol.276
, pp. 14890-14895
-
-
Listenberger, L.L.1
Ory, D.S.2
Schaffer, J.E.3
-
137
-
-
84937590608
-
Antioxidant mechanisms in nonalcoholic fatty liver disease
-
1:CAS:528:DC%2BC2MXhslGitbbN 25915484
-
Liu W, Baker SS, Baker RD, Zhu L (2015) Antioxidant mechanisms in nonalcoholic fatty liver disease. Curr Drug Targets 16:1301-1314
-
(2015)
Curr Drug Targets
, vol.16
, pp. 1301-1314
-
-
Liu, W.1
Baker, S.S.2
Baker, R.D.3
Zhu, L.4
-
138
-
-
84890129317
-
Paraoxonase 1 and oxidative stress in paediatric non-alcoholic steatohepatitis
-
1:CAS:528:DC%2BC3sXhvFaks7fK 24028323
-
Desai S, Baker SS, Liu W, Moya DA, Browne RW, Mastrandrea L, Baker RD, Zhu L (2014) Paraoxonase 1 and oxidative stress in paediatric non-alcoholic steatohepatitis. Liver Int 34:110-117
-
(2014)
Liver Int
, vol.34
, pp. 110-117
-
-
Desai, S.1
Baker, S.S.2
Liu, W.3
Moya, D.A.4
Browne, R.W.5
Mastrandrea, L.6
Baker, R.D.7
Zhu, L.8
-
139
-
-
80052637451
-
Upregulation of hemoglobin expression by oxidative stress in hepatocytes and its implication in nonalcoholic steatohepatitis
-
1:CAS:528:DC%2BC3MXht1Glt7vF 21931690 3171444
-
Liu W, Baker SS, Baker RD, Nowak NJ, Zhu L (2011) Upregulation of hemoglobin expression by oxidative stress in hepatocytes and its implication in nonalcoholic steatohepatitis. PLoS One 6:e24363
-
(2011)
PLoS One
, vol.6
, pp. e24363
-
-
Liu, W.1
Baker, S.S.2
Baker, R.D.3
Nowak, N.J.4
Zhu, L.5
-
140
-
-
77949677097
-
Role of alcohol metabolism in non-alcoholic steatohepatitis
-
20221393 2833196
-
Baker SS, Baker RD, Liu W, Nowak NJ, Zhu L (2010) Role of alcohol metabolism in non-alcoholic steatohepatitis. PLoS One 5:e9570
-
(2010)
PLoS One
, vol.5
, pp. e9570
-
-
Baker, S.S.1
Baker, R.D.2
Liu, W.3
Nowak, N.J.4
Zhu, L.5
-
141
-
-
84928651171
-
Novel pathway for iron deficiency in pediatric non-alcoholic steatohepatitis
-
Moya D, Baker SS, Liu W, Garrick M, Kozielski R, Baker RD, Zhu L (2014) Novel pathway for iron deficiency in pediatric non-alcoholic steatohepatitis. Clin Nutr 34(3):549-556. doi: 10.1016/j.clnu.2014.06.011
-
(2014)
Clin Nutr
, vol.34
, Issue.3
, pp. 549-556
-
-
Moya, D.1
Baker, S.S.2
Liu, W.3
Garrick, M.4
Kozielski, R.5
Baker, R.D.6
Zhu, L.7
-
142
-
-
84910147372
-
Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease
-
25339807 4202349
-
Paradies G, Paradies V, Ruggiero FM, Petrosillo G (2014) Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease. World J Gastroenterol 20:14205-14218
-
(2014)
World J Gastroenterol
, vol.20
, pp. 14205-14218
-
-
Paradies, G.1
Paradies, V.2
Ruggiero, F.M.3
Petrosillo, G.4
-
143
-
-
84899764290
-
Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH)
-
24786095 4057677
-
Takaki A, Kawai D, Yamamoto K (2014) Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH). Int J Mol Sci 15:7352-7379
-
(2014)
Int J Mol Sci
, vol.15
, pp. 7352-7379
-
-
Takaki, A.1
Kawai, D.2
Yamamoto, K.3
-
144
-
-
84655169624
-
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
-
1:CAS:528:DC%2BC38Xitlymsw%3D%3D 22064361
-
Rolo AP, Teodoro JS, Palmeira CM (2012) Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med 52:59-69
-
(2012)
Free Radic Biol Med
, vol.52
, pp. 59-69
-
-
Rolo, A.P.1
Teodoro, J.S.2
Palmeira, C.M.3
-
145
-
-
78049280638
-
Morbid obesity in pediatric diabetes mellitus: Surgical options and outcomes
-
20842181
-
Brandt ML, Harmon CM, Helmrath MA, Inge TH, McKay SV, Michalsky MP (2010) Morbid obesity in pediatric diabetes mellitus: surgical options and outcomes. Nat Rev Endocrinol 6:637-645
-
(2010)
Nat Rev Endocrinol
, vol.6
, pp. 637-645
-
-
Brandt, M.L.1
Harmon, C.M.2
Helmrath, M.A.3
Inge, T.H.4
McKay, S.V.5
Michalsky, M.P.6
-
146
-
-
84894234845
-
Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease
-
1:CAS:528:DC%2BC2cXhtlOgt77F 24587654 3930975
-
Zhang XQ, Xu CF, Yu CH, Chen WX, Li YM (2014) Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol 20:1768-1776
-
(2014)
World J Gastroenterol
, vol.20
, pp. 1768-1776
-
-
Zhang, X.Q.1
Xu, C.F.2
Yu, C.H.3
Chen, W.X.4
Li, Y.M.5
-
147
-
-
84929653472
-
Endoplasmic reticulum stress response in non-alcoholic steatohepatitis: The possible role of physical exercise
-
1:CAS:528:DC%2BC2MXlsFGqurk%3D 25838034
-
Passos E, Ascensao A, Martins MJ, Magalhaes J (2015) Endoplasmic reticulum stress response in non-alcoholic steatohepatitis: the possible role of physical exercise. Metabolism 64:780-792
-
(2015)
Metabolism
, vol.64
, pp. 780-792
-
-
Passos, E.1
Ascensao, A.2
Martins, M.J.3
Magalhaes, J.4
-
148
-
-
84946494125
-
Endoplasmic reticulum stress and oxidative stress in the pathogenesis of non-alcoholic fatty liver disease
-
1:CAS:528:DC%2BC2MXhslKks7rM 26223319
-
Ashraf NU, Sheikh TA (2015) Endoplasmic reticulum stress and oxidative stress in the pathogenesis of non-alcoholic fatty liver disease. Free Radic Res 49:1405-1418
-
(2015)
Free Radic Res
, vol.49
, pp. 1405-1418
-
-
Ashraf, N.U.1
Sheikh, T.A.2
-
149
-
-
79960299426
-
Non-alcoholic fatty liver disease: What's new under the microscope?
-
21303916
-
Brunt EM (2011) Non-alcoholic fatty liver disease: what's new under the microscope? Gut 60:1152-1158
-
(2011)
Gut
, vol.60
, pp. 1152-1158
-
-
Brunt, E.M.1
-
150
-
-
84913545865
-
Pathological features of fatty liver disease
-
1:CAS:528:DC%2BC2cXhsF2murzF 25109884
-
Yeh MM, Brunt EM (2014) Pathological features of fatty liver disease. Gastroenterology 147:754-764
-
(2014)
Gastroenterology
, vol.147
, pp. 754-764
-
-
Yeh, M.M.1
Brunt, E.M.2
-
151
-
-
40949123364
-
Ballooned hepatocytes in steatohepatitis: The value of keratin immunohistochemistry for diagnosis
-
1:CAS:528:DC%2BD1cXktVGruro%3D 18329127
-
Lackner C, Gogg-Kamerer M, Zatloukal K, Stumptner C, Brunt EM, Denk H (2008) Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis. J Hepatol 48:821-828
-
(2008)
J Hepatol
, vol.48
, pp. 821-828
-
-
Lackner, C.1
Gogg-Kamerer, M.2
Zatloukal, K.3
Stumptner, C.4
Brunt, E.M.5
Denk, H.6
-
152
-
-
84890215304
-
Modification and inactivation of Cu, Zn-superoxide dismutase by the lipid peroxidation product, acrolein
-
1:CAS:528:DC%2BC3sXhvVyitLbN 24152914 4133839
-
Kang JH (2013) Modification and inactivation of Cu, Zn-superoxide dismutase by the lipid peroxidation product, acrolein. BMB Rep 46:555-560
-
(2013)
BMB Rep
, vol.46
, pp. 555-560
-
-
Kang, J.H.1
-
153
-
-
0025057048
-
Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals
-
1:CAS:528:DyaK3cXhsleksLY%3D 2308398
-
Pigeolet E, Corbisier P, Houbion A, Lambert D, Michiels C, Raes M, Zachary MD, Remacle J (1990) Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals. Mech Ageing Dev 51:283-297
-
(1990)
Mech Ageing Dev
, vol.51
, pp. 283-297
-
-
Pigeolet, E.1
Corbisier, P.2
Houbion, A.3
Lambert, D.4
Michiels, C.5
Raes, M.6
Zachary, M.D.7
Remacle, J.8
-
154
-
-
0036080591
-
Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis
-
1:CAS:528:DC%2BD38XhtFGitbk%3D 11804839
-
Pessayre D, Mansouri A, Fromenty B (2002) Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis. Am J Physiol Gastrointest Liver Physiol 282:G193-G199
-
(2002)
Am J Physiol Gastrointest Liver Physiol
, vol.282
, pp. G193-G199
-
-
Pessayre, D.1
Mansouri, A.2
Fromenty, B.3
-
155
-
-
0036783050
-
The metabolic abnormalities associated with non-alcoholic fatty liver disease
-
1:CAS:528:DC%2BD3sXkvFKgsL0%3D 12406441
-
Haque M, Sanyal AJ (2002) The metabolic abnormalities associated with non-alcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 16:709-731
-
(2002)
Best Pract Res Clin Gastroenterol
, vol.16
, pp. 709-731
-
-
Haque, M.1
Sanyal, A.J.2
-
156
-
-
79956301571
-
The role of oxidative stress in non-alcoholic steatohepatitis
-
1:CAS:528:DC%2BC3MXmslOltb0%3D 21514287
-
Koek GH, Liedorp PR, Bast A (2011) The role of oxidative stress in non-alcoholic steatohepatitis. Clin Chim Acta 412:1297-1305
-
(2011)
Clin Chim Acta
, vol.412
, pp. 1297-1305
-
-
Koek, G.H.1
Liedorp, P.R.2
Bast, A.3
-
157
-
-
0033520771
-
Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: A pilot study
-
1:CAS:528:DyaK1MXnsFGmsb4%3D 10553793
-
Cortez-Pinto H, Chatham J, Chacko VP, Arnold C, Rashid A, Diehl AM (1999) Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA 282:1659-1664
-
(1999)
JAMA
, vol.282
, pp. 1659-1664
-
-
Cortez-Pinto, H.1
Chatham, J.2
Chacko, V.P.3
Arnold, C.4
Rashid, A.5
Diehl, A.M.6
-
158
-
-
18144444592
-
Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis
-
1:CAS:528:DC%2BD3sXovFGhurY%3D 14512887
-
Perez-Carreras M, Del Hoyo P, Martin MA, Rubio JC, Martin A, Castellano G, Colina F, Arenas J, Solis-Herruzo JA (2003) Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 38:999-1007
-
(2003)
Hepatology
, vol.38
, pp. 999-1007
-
-
Perez-Carreras, M.1
Del Hoyo, P.2
Martin, M.A.3
Rubio, J.C.4
Martin, A.5
Castellano, G.6
Colina, F.7
Arenas, J.8
Solis-Herruzo, J.A.9
-
159
-
-
0033198978
-
Mitochondrial abnormalities in non-alcoholic steatohepatitis
-
1:CAS:528:DyaK1MXmtFKnsr4%3D 10488700
-
Caldwell SH, Swerdlow RH, Khan EM, Iezzoni JC, Hespenheide EE, Parks JK, Parker WD Jr (1999) Mitochondrial abnormalities in non-alcoholic steatohepatitis. J Hepatol 31:430-434
-
(1999)
J Hepatol
, vol.31
, pp. 430-434
-
-
Caldwell, S.H.1
Swerdlow, R.H.2
Khan, E.M.3
Iezzoni, J.C.4
Hespenheide, E.E.5
Parks, J.K.6
Parker, W.D.7
-
160
-
-
0035991444
-
In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases
-
1:CAS:528:DC%2BD38XksFymu7s%3D 12076862
-
Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K, Wakasa K (2002) In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol 37:56-62
-
(2002)
J Hepatol
, vol.37
, pp. 56-62
-
-
Seki, S.1
Kitada, T.2
Yamada, T.3
Sakaguchi, H.4
Nakatani, K.5
Wakasa, K.6
-
161
-
-
84900793058
-
Evolving concepts in the pathogenesis of NASH: Beyond steatosis and inflammation
-
1:CAS:528:DC%2BC2MXjtFyntLc%3D 24830559 4057750
-
Peverill W, Powell LW, Skoien R (2014) Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation. Int J Mol Sci 15:8591-8638
-
(2014)
Int J Mol Sci
, vol.15
, pp. 8591-8638
-
-
Peverill, W.1
Powell, L.W.2
Skoien, R.3
-
162
-
-
0042165989
-
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
-
12891546
-
Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ (2003) Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125:437-443
-
(2003)
Gastroenterology
, vol.125
, pp. 437-443
-
-
Feldstein, A.E.1
Canbay, A.2
Angulo, P.3
Taniai, M.4
Burgart, L.J.5
Lindor, K.D.6
Gores, G.J.7
-
163
-
-
84885172990
-
Depending on the stage of hepatosteatosis, p53 causes apoptosis primarily through either DRAM-induced autophagy or BAX
-
1:CAS:528:DC%2BC3sXhs1Slsr%2FL 23875779 4283711
-
Liu K, Lou J, Wen T, Yin J, Xu B, Ding W, Wang A, Liu D, Zhang C, Chen D, Li N (2013) Depending on the stage of hepatosteatosis, p53 causes apoptosis primarily through either DRAM-induced autophagy or BAX. Liver Int 33:1566-1574
-
(2013)
Liver Int
, vol.33
, pp. 1566-1574
-
-
Liu, K.1
Lou, J.2
Wen, T.3
Yin, J.4
Xu, B.5
Ding, W.6
Wang, A.7
Liu, D.8
Zhang, C.9
Chen, D.10
Li, N.11
-
164
-
-
63049134573
-
Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression
-
1:CAS:528:DC%2BD1MXltFCgtLk%3D 19226377
-
Farrell GC, Larter CZ, Hou JY, Zhang RH, Yeh MM, Williams J, dela Pena A, Francisco R, Osvath SR, Brooling J, Teoh N, Sedger LM (2009) Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression. J Gastroenterol Hepatol 24:443-452
-
(2009)
J Gastroenterol Hepatol
, vol.24
, pp. 443-452
-
-
Farrell, G.C.1
Larter, C.Z.2
Hou, J.Y.3
Zhang, R.H.4
Yeh, M.M.5
Williams, J.6
Dela Pena, A.7
Francisco, R.8
Osvath, S.R.9
Brooling, J.10
Teoh, N.11
Sedger, L.M.12
-
165
-
-
2442656430
-
P53 involvement in the pathogenesis of fatty liver disease
-
1:CAS:528:DC%2BD2cXjvV2gu78%3D 14985341
-
Yahagi N, Shimano H, Matsuzaka T, Sekiya M, Najima Y, Okazaki S, Okazaki H, Tamura Y, Iizuka Y, Inoue N, Nakagawa Y, Takeuchi Y, Ohashi K, Harada K, Gotoda T, Nagai R, Kadowaki T, Ishibashi S, Osuga J, Yamada N (2004) p53 involvement in the pathogenesis of fatty liver disease. J Biol Chem 279:20571-20575
-
(2004)
J Biol Chem
, vol.279
, pp. 20571-20575
-
-
Yahagi, N.1
Shimano, H.2
Matsuzaka, T.3
Sekiya, M.4
Najima, Y.5
Okazaki, S.6
Okazaki, H.7
Tamura, Y.8
Iizuka, Y.9
Inoue, N.10
Nakagawa, Y.11
Takeuchi, Y.12
Ohashi, K.13
Harada, K.14
Gotoda, T.15
Nagai, R.16
Kadowaki, T.17
Ishibashi, S.18
Osuga, J.19
Yamada, N.20
more..
-
166
-
-
33750628734
-
Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease
-
1:CAS:528:DC%2BD28Xht1emtL%2FK 17036395 4088117
-
Panasiuk A, Dzieciol J, Panasiuk B, Prokopowicz D (2006) Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease. World J Gastroenterol 12:6198-6202
-
(2006)
World J Gastroenterol
, vol.12
, pp. 6198-6202
-
-
Panasiuk, A.1
Dzieciol, J.2
Panasiuk, B.3
Prokopowicz, D.4
-
167
-
-
84989336849
-
ER stress induces NLRP3 inflammasome activation and hepatocyte death
-
1:CAS:528:DC%2BC2MXhsV2gtbjK 26355342 4650444
-
Lebeaupin C, Proics E, de Bieville CH, Rousseau D, Bonnafous S, Patouraux S, Adam G, Lavallard VJ, Rovere C, Le Thuc O, Saint-Paul MC, Anty R, Schneck AS, Iannelli A, Gugenheim J, Tran A, Gual P, Bailly-Maitre B (2015) ER stress induces NLRP3 inflammasome activation and hepatocyte death. Cell Death Dis 6:e1879
-
(2015)
Cell Death Dis
, vol.6
, pp. e1879
-
-
Lebeaupin, C.1
Proics, E.2
De Bieville, C.H.3
Rousseau, D.4
Bonnafous, S.5
Patouraux, S.6
Adam, G.7
Lavallard, V.J.8
Rovere, C.9
Le Thuc, O.10
Saint-Paul, M.C.11
Anty, R.12
Schneck, A.S.13
Iannelli, A.14
Gugenheim, J.15
Tran, A.16
Gual, P.17
Bailly-Maitre, B.18
-
168
-
-
77954363354
-
Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis
-
1:CAS:528:DC%2BC3cXovFSjtbk%3D 20408954
-
Bechmann LP, Gieseler RK, Sowa JP, Kahraman A, Erhard J, Wedemeyer I, Emons B, Jochum C, Feldkamp T, Gerken G, Canbay A (2010) Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis. Liver Int 30:850-859
-
(2010)
Liver Int
, vol.30
, pp. 850-859
-
-
Bechmann, L.P.1
Gieseler, R.K.2
Sowa, J.P.3
Kahraman, A.4
Erhard, J.5
Wedemeyer, I.6
Emons, B.7
Jochum, C.8
Feldkamp, T.9
Gerken, G.10
Canbay, A.11
-
169
-
-
0348134733
-
Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice
-
1:CAS:528:DC%2BD3sXpt1egtLc%3D 14642615
-
Feldstein AE, Canbay A, Guicciardi ME, Higuchi H, Bronk SF, Gores GJ (2003) Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. J Hepatol 39:978-983
-
(2003)
J Hepatol
, vol.39
, pp. 978-983
-
-
Feldstein, A.E.1
Canbay, A.2
Guicciardi, M.E.3
Higuchi, H.4
Bronk, S.F.5
Gores, G.J.6
-
170
-
-
0348230958
-
Obesity is associated with macrophage accumulation in adipose tissue
-
1:CAS:528:DC%2BD3sXhtVSmtLvO 14679176 296995
-
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808
-
(2003)
J Clin Invest
, vol.112
, pp. 1796-1808
-
-
Weisberg, S.P.1
McCann, D.2
Desai, M.3
Rosenbaum, M.4
Leibel, R.L.5
Ferrante, A.W.6
-
171
-
-
37349006913
-
TNF-alpha and adipocyte biology
-
1:CAS:528:DC%2BD2sXhsVOltbzL 18037376 4304634
-
Cawthorn WP, Sethi JK (2008) TNF-alpha and adipocyte biology. FEBS Lett 582:117-131
-
(2008)
FEBS Lett
, vol.582
, pp. 117-131
-
-
Cawthorn, W.P.1
Sethi, J.K.2
-
172
-
-
84906064344
-
Kupffer cells: Increasingly significant role in nonalcoholic fatty liver disease
-
25152980
-
Wenfeng Z, Yakun W, Di M, Jianping G, Chuanxin W, Chun H (2014) Kupffer cells: increasingly significant role in nonalcoholic fatty liver disease. Ann Hepatol 13:489-495
-
(2014)
Ann Hepatol
, vol.13
, pp. 489-495
-
-
Wenfeng, Z.1
Yakun, W.2
Di, M.3
Jianping, G.4
Chuanxin, W.5
Chun, H.6
-
173
-
-
67349205002
-
Kupffer cells in non-alcoholic fatty liver disease: The emerging view
-
1:CAS:528:DC%2BD1MXntVKgu74%3D 19447517 2694233
-
Baffy G (2009) Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol 51:212-223
-
(2009)
J Hepatol
, vol.51
, pp. 212-223
-
-
Baffy, G.1
-
174
-
-
84881320210
-
Pathophysiology of NASH: Perspectives for a targeted treatment
-
1:CAS:528:DC%2BC3sXht1GlsrvK 23394092 3984586
-
Marra F, Lotersztajn S (2013) Pathophysiology of NASH: perspectives for a targeted treatment. Curr Pharm Des 19:5250-5269
-
(2013)
Curr Pharm des
, vol.19
, pp. 5250-5269
-
-
Marra, F.1
Lotersztajn, S.2
-
175
-
-
84894798789
-
M2 Kupffer cells promote M1 Kupffer cell apoptosis: A protective mechanism against alcoholic and nonalcoholic fatty liver disease
-
1:CAS:528:DC%2BC2cXltVGj 23832548
-
Wan J, Benkdane M, Teixeira-Clerc F, Bonnafous S, Louvet A, Lafdil F, Pecker F, Tran A, Gual P, Mallat A, Lotersztajn S, Pavoine C (2014) M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology 59:130-142
-
(2014)
Hepatology
, vol.59
, pp. 130-142
-
-
Wan, J.1
Benkdane, M.2
Teixeira-Clerc, F.3
Bonnafous, S.4
Louvet, A.5
Lafdil, F.6
Pecker, F.7
Tran, A.8
Gual, P.9
Mallat, A.10
Lotersztajn, S.11
Pavoine, C.12
-
176
-
-
84899038416
-
Liver disease: Kupffer cells regulate the progression of ALD and NAFLD
-
23877532
-
Smith K (2013) Liver disease: Kupffer cells regulate the progression of ALD and NAFLD. Nat Rev Gastroenterol Hepatol 10:503
-
(2013)
Nat Rev Gastroenterol Hepatol
, vol.10
, pp. 503
-
-
Smith, K.1
-
178
-
-
33750312176
-
Histological assessment of non-alcoholic fatty liver disease
-
1:STN:280:DC%2BD28njtFaiug%3D%3D 17064291
-
Hubscher SG (2006) Histological assessment of non-alcoholic fatty liver disease. Histopathology 49:450-465
-
(2006)
Histopathology
, vol.49
, pp. 450-465
-
-
Hubscher, S.G.1
-
179
-
-
71149086343
-
Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis
-
1:CAS:528:DC%2BD1MXhtlWiurzM 19729473 2751544
-
Rensen SS, Slaats Y, Nijhuis J, Jans A, Bieghs V, Driessen A, Malle E, Greve JW, Buurman WA (2009) Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis. Am J Pathol 175:1473-1482
-
(2009)
Am J Pathol
, vol.175
, pp. 1473-1482
-
-
Rensen, S.S.1
Slaats, Y.2
Nijhuis, J.3
Jans, A.4
Bieghs, V.5
Driessen, A.6
Malle, E.7
Greve, J.W.8
Buurman, W.A.9
-
180
-
-
70350565467
-
Neutrophil activation in morbid obesity, chronic activation of acute inflammation
-
1:CAS:528:DC%2BD1MXhtlWisLrK
-
Nijhuis J, Rensen SS, Slaats Y, van Dielen FM, Buurman WA, Greve JW (2009) Neutrophil activation in morbid obesity, chronic activation of acute inflammation. Obesity (Silver Spring) 17:2014-2018
-
(2009)
Obesity (Silver Spring)
, vol.17
, pp. 2014-2018
-
-
Nijhuis, J.1
Rensen, S.S.2
Slaats, Y.3
Van Dielen, F.M.4
Buurman, W.A.5
Greve, J.W.6
-
181
-
-
84899560268
-
Metabolically induced liver inflammation leads to NASH and differs from LPS- or IL-1beta-induced chronic inflammation
-
1:CAS:528:DC%2BC2cXjt1Wisb4%3D 24566933
-
Liang W, Lindeman JH, Menke AL, Koonen DP, Morrison M, Havekes LM, van den Hoek AM, Kleemann R (2014) Metabolically induced liver inflammation leads to NASH and differs from LPS- or IL-1beta-induced chronic inflammation. Lab Invest 94:491-502
-
(2014)
Lab Invest
, vol.94
, pp. 491-502
-
-
Liang, W.1
Lindeman, J.H.2
Menke, A.L.3
Koonen, D.P.4
Morrison, M.5
Havekes, L.M.6
Van Den Hoek, A.M.7
Kleemann, R.8
-
182
-
-
84938302586
-
Development of steatohepatitis in Ob/Ob mice is dependent on Toll-like receptor 4
-
26256903
-
Sutter AG, Palanisamy AP, Lench JH, Jessmore AP, Chavin KD (2015) Development of steatohepatitis in Ob/Ob mice is dependent on Toll-like receptor 4. Ann Hepatol 14:735-743
-
(2015)
Ann Hepatol
, vol.14
, pp. 735-743
-
-
Sutter, A.G.1
Palanisamy, A.P.2
Lench, J.H.3
Jessmore, A.P.4
Chavin, K.D.5
-
183
-
-
84956905459
-
Small intestinal bacterial overgrowth and toll like receptor signaling in patients with nonalcoholic fatty liver disease
-
Kapil S, Duseja A, Sharma BK, Singla B, Chakraborti A, Das A, Ray P, Dhiman RK, Chawla Y (2015) Small intestinal bacterial overgrowth and toll like receptor signaling in patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol 31(1): 213-21. doi: 10.1111/jgh.13058
-
(2015)
J Gastroenterol Hepatol
, vol.31
, Issue.1
, pp. 213-221
-
-
Kapil, S.1
Duseja, A.2
Sharma, B.K.3
Singla, B.4
Chakraborti, A.5
Das, A.6
Ray, P.7
Dhiman, R.K.8
Chawla, Y.9
-
184
-
-
84900538053
-
Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis
-
1:CAS:528:DC%2BC2cXot1yitbk%3D 24372861
-
Yuan J, Baker SS, Liu W, Alkhouri R, Baker RD, Xie J, Ji G, Zhu L (2014) Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis. J Gastroenterol Hepatol 29:1292-1298
-
(2014)
J Gastroenterol Hepatol
, vol.29
, pp. 1292-1298
-
-
Yuan, J.1
Baker, S.S.2
Liu, W.3
Alkhouri, R.4
Baker, R.D.5
Xie, J.6
Ji, G.7
Zhu, L.8
-
185
-
-
84864657351
-
Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
-
1:CAS:528:DC%2BC38XhtFWms73L 22842477
-
Pal D, Dasgupta S, Kundu R, Maitra S, Das G, Mukhopadhyay S, Ray S, Majumdar SS, Bhattacharya S (2012) Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med 18:1279-1285
-
(2012)
Nat Med
, vol.18
, pp. 1279-1285
-
-
Pal, D.1
Dasgupta, S.2
Kundu, R.3
Maitra, S.4
Das, G.5
Mukhopadhyay, S.6
Ray, S.7
Majumdar, S.S.8
Bhattacharya, S.9
-
186
-
-
73949110679
-
Saturated fatty acids do not directly stimulate Toll-like receptor signaling
-
1:CAS:528:DC%2BD1MXht1ymsr7F 19661481
-
Erridge C, Samani NJ (2009) Saturated fatty acids do not directly stimulate Toll-like receptor signaling. Arterioscler Thromb Vasc Biol 29:1944-1949
-
(2009)
Arterioscler Thromb Vasc Biol
, vol.29
, pp. 1944-1949
-
-
Erridge, C.1
Samani, N.J.2
-
187
-
-
84928947939
-
Fatty acids induce a pro-inflammatory gene expression profile in Huh-7 cells that attenuates the anti-HCV action of interferon
-
1:CAS:528:DC%2BC2MXns1Ghtbo%3D 25588104
-
Tse E, Helbig KJ, Van der Hoek K, McCartney EM, Van der Hoek M, George J, Beard MR (2015) Fatty acids induce a pro-inflammatory gene expression profile in Huh-7 cells that attenuates the anti-HCV action of interferon. J Interferon Cytokine Res 35:392-400
-
(2015)
J Interferon Cytokine Res
, vol.35
, pp. 392-400
-
-
Tse, E.1
Helbig, K.J.2
Van Der Hoek, K.3
McCartney, E.M.4
Van Der Hoek, M.5
George, J.6
Beard, M.R.7
-
188
-
-
84873289589
-
Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice
-
1:CAS:528:DC%2BC3sXit1WgtL0%3D 22987396 3566276
-
Miura K, Yang L, van Rooijen N, Brenner DA, Ohnishi H, Seki E (2013) Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice. Hepatology 57:577-589
-
(2013)
Hepatology
, vol.57
, pp. 577-589
-
-
Miura, K.1
Yang, L.2
Van Rooijen, N.3
Brenner, D.A.4
Ohnishi, H.5
Seki, E.6
-
189
-
-
84930959966
-
How inflammation impinges on NAFLD: A role for Kupffer cells
-
26090470 4450298
-
Duarte N, Coelho IC, Patarrao RS, Almeida JI, Penha-Goncalves C, Macedo MP (2015) How inflammation impinges on NAFLD: a role for Kupffer cells. Biomed Res Int 2015:984578
-
(2015)
Biomed Res Int
, vol.2015
, pp. 984578
-
-
Duarte, N.1
Coelho, I.C.2
Patarrao, R.S.3
Almeida, J.I.4
Penha-Goncalves, C.5
Macedo, M.P.6
-
190
-
-
84902655291
-
Role of autophagy in the pathophysiology of nonalcoholic fatty liver disease: A controversial issue
-
24966603 4064078
-
Kwanten WJ, Martinet W, Michielsen PP, Francque SM (2014) Role of autophagy in the pathophysiology of nonalcoholic fatty liver disease: a controversial issue. World J Gastroenterol 20:7325-7338
-
(2014)
World J Gastroenterol
, vol.20
, pp. 7325-7338
-
-
Kwanten, W.J.1
Martinet, W.2
Michielsen, P.P.3
Francque, S.M.4
-
191
-
-
84944316845
-
Genetic background in nonalcoholic fatty liver disease: A comprehensive review
-
26494964 4607907
-
Macaluso FS, Maida M, Petta S (2015) Genetic background in nonalcoholic fatty liver disease: a comprehensive review. World J Gastroenterol 21:11088-11111
-
(2015)
World J Gastroenterol
, vol.21
, pp. 11088-11111
-
-
Macaluso, F.S.1
Maida, M.2
Petta, S.3
-
192
-
-
81855213130
-
Nonalcoholic steatohepatitis: The therapeutic challenge of a global epidemic
-
1:CAS:528:DC%2BC3MXhsVyksLjL 22002020
-
Schattenberg JM, Schuppan D (2011) Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic. Curr Opin Lipidol 22:479-488
-
(2011)
Curr Opin Lipidol
, vol.22
, pp. 479-488
-
-
Schattenberg, J.M.1
Schuppan, D.2
-
193
-
-
84893141250
-
Hepatic stellate cells and liver fibrosis
-
24265236
-
Puche JE, Saiman Y, Friedman SL (2013) Hepatic stellate cells and liver fibrosis. Compr Physiol 3:1473-1492
-
(2013)
Compr Physiol
, vol.3
, pp. 1473-1492
-
-
Puche, J.E.1
Saiman, Y.2
Friedman, S.L.3
-
194
-
-
84856976151
-
What's new in liver fibrosis? the origin of myofibroblasts in liver fibrosis
-
1:CAS:528:DC%2BC38Xltlaktrs%3D 22320919
-
Iwaisako K, Brenner DA, Kisseleva T (2012) What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis. J Gastroenterol Hepatol 27(Suppl 2):65-68
-
(2012)
J Gastroenterol Hepatol
, vol.27
, pp. 65-68
-
-
Iwaisako, K.1
Brenner, D.A.2
Kisseleva, T.3
-
195
-
-
85035392112
-
Liver fibrosis
-
1:CAS:528:DC%2BD2MXhtFyjs70%3D 15690074 546435
-
Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115:209-218
-
(2005)
J Clin Invest
, vol.115
, pp. 209-218
-
-
Bataller, R.1
Brenner, D.A.2
-
196
-
-
35948954244
-
Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver
-
1:CAS:528:DC%2BD1cXitVKgsbc%3D 18195085 2888531
-
Friedman SL (2008) Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88:125-172
-
(2008)
Physiol Rev
, vol.88
, pp. 125-172
-
-
Friedman, S.L.1
-
197
-
-
84867723466
-
Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease
-
1:CAS:528:DC%2BC38XhvVSmtb%2FP 22467277
-
Nobili V, Carpino G, Alisi A, Franchitto A, Alpini G, De Vito R, Onori P, Alvaro D, Gaudio E (2012) Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease. Hepatology 56:2142-2153
-
(2012)
Hepatology
, vol.56
, pp. 2142-2153
-
-
Nobili, V.1
Carpino, G.2
Alisi, A.3
Franchitto, A.4
Alpini, G.5
De Vito, R.6
Onori, P.7
Alvaro, D.8
Gaudio, E.9
-
198
-
-
2542601615
-
Liver regeneration and repair: Hepatocytes, progenitor cells, and stem cells
-
15185286
-
Fausto N (2004) Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology 39:1477-1487
-
(2004)
Hepatology
, vol.39
, pp. 1477-1487
-
-
Fausto, N.1
-
199
-
-
84941935061
-
Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease
-
1:CAS:528:DC%2BC2MXht1amsLfK 26070409
-
Machado MV, Michelotti GA, Pereira TA, Xie G, Premont R, Cortez-Pinto H, Diehl AM (2015) Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease. J Hepatol 63:962-970
-
(2015)
J Hepatol
, vol.63
, pp. 962-970
-
-
Machado, M.V.1
Michelotti, G.A.2
Pereira, T.A.3
Xie, G.4
Premont, R.5
Cortez-Pinto, H.6
Diehl, A.M.7
-
200
-
-
84869751765
-
Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice
-
Espanol-Suner R, Carpentier R, Van Hul N, Legry V, Achouri Y, Cordi S, Jacquemin P, Lemaigre F, Leclercq IA (2012) Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice. Gastroenterology 143(1564-1575):e1567
-
(2012)
Gastroenterology
, vol.143
, Issue.1564-1575
, pp. e1567
-
-
Espanol-Suner, R.1
Carpentier, R.2
Van Hul, N.3
Legry, V.4
Achouri, Y.5
Cordi, S.6
Jacquemin, P.7
Lemaigre, F.8
Leclercq, I.A.9
-
201
-
-
80055051680
-
Ductular reactions in human liver: Diversity at the interface
-
21983984
-
Gouw AS, Clouston AD, Theise ND (2011) Ductular reactions in human liver: diversity at the interface. Hepatology 54:1853-1863
-
(2011)
Hepatology
, vol.54
, pp. 1853-1863
-
-
Gouw, A.S.1
Clouston, A.D.2
Theise, N.D.3
-
202
-
-
84859445823
-
TGF-beta in progression of liver disease
-
1:CAS:528:DC%2BC38XkslCjsA%3D%3D 22006249 3250614
-
Dooley S, ten Dijke P (2012) TGF-beta in progression of liver disease. Cell Tissue Res 347:245-256
-
(2012)
Cell Tissue Res
, vol.347
, pp. 245-256
-
-
Dooley, S.1
Ten Dijke, P.2
-
203
-
-
36348932917
-
Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes
-
1:CAS:528:DC%2BD2sXht1aksrvJ 17657819
-
Weng HL, Ciuclan L, Liu Y, Hamzavi J, Godoy P, Gaitantzi H, Kanzler S, Heuchel R, Ueberham U, Gebhardt R, Breitkopf K, Dooley S (2007) Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes. Hepatology 46:1257-1270
-
(2007)
Hepatology
, vol.46
, pp. 1257-1270
-
-
Weng, H.L.1
Ciuclan, L.2
Liu, Y.3
Hamzavi, J.4
Godoy, P.5
Gaitantzi, H.6
Kanzler, S.7
Heuchel, R.8
Ueberham, U.9
Gebhardt, R.10
Breitkopf, K.11
Dooley, S.12
-
204
-
-
0033854016
-
Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats
-
1:CAS:528:DC%2BD3cXlvVyjt74%3D 10915731
-
Nakamura T, Sakata R, Ueno T, Sata M, Ueno H (2000) Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Hepatology 32:247-255
-
(2000)
Hepatology
, vol.32
, pp. 247-255
-
-
Nakamura, T.1
Sakata, R.2
Ueno, T.3
Sata, M.4
Ueno, H.5
-
205
-
-
0033109090
-
TGF-beta1 in liver fibrosis: An inducible transgenic mouse model to study liver fibrogenesis
-
1:CAS:528:DyaK1MXislCrs7o%3D 10198351
-
Kanzler S, Lohse AW, Keil A, Henninger J, Dienes HP, Schirmacher P, Rose-John S, Buschenfelde KH, Blessing M (1999) TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am J Physiol 276:G1059-G1068
-
(1999)
Am J Physiol
, vol.276
, pp. G1059-G1068
-
-
Kanzler, S.1
Lohse, A.W.2
Keil, A.3
Henninger, J.4
Dienes, H.P.5
Schirmacher, P.6
Rose-John, S.7
Buschenfelde, K.H.8
Blessing, M.9
-
206
-
-
0031587828
-
The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling
-
1:CAS:528:DyaK2sXkt1Kks70%3D 9215638
-
Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, Richardson MA, Topper JN, Gimbrone MA Jr, Wrana JL, Falb D (1997) The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 89:1165-1173
-
(1997)
Cell
, vol.89
, pp. 1165-1173
-
-
Hayashi, H.1
Abdollah, S.2
Qiu, Y.3
Cai, J.4
Xu, Y.Y.5
Grinnell, B.W.6
Richardson, M.A.7
Topper, J.N.8
Gimbrone, M.A.9
Wrana, J.L.10
Falb, D.11
-
207
-
-
18244401140
-
Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury
-
1:CAS:528:DC%2BD38XmvFaruw%3D%3D 11786959
-
Tahashi Y, Matsuzaki K, Date M, Yoshida K, Furukawa F, Sugano Y, Matsushita M, Himeno Y, Inagaki Y, Inoue K (2002) Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology 35:49-61
-
(2002)
Hepatology
, vol.35
, pp. 49-61
-
-
Tahashi, Y.1
Matsuzaki, K.2
Date, M.3
Yoshida, K.4
Furukawa, F.5
Sugano, Y.6
Matsushita, M.7
Himeno, Y.8
Inagaki, Y.9
Inoue, K.10
-
208
-
-
71049139747
-
Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-beta signaling
-
1:CAS:528:DC%2BD1MXhtlSrurfF 19758997 2781564
-
Yan X, Lin Z, Chen F, Zhao X, Chen H, Ning Y, Chen YG (2009) Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-beta signaling. J Biol Chem 284:30097-30104
-
(2009)
J Biol Chem
, vol.284
, pp. 30097-30104
-
-
Yan, X.1
Lin, Z.2
Chen, F.3
Zhao, X.4
Chen, H.5
Ning, Y.6
Chen, Y.G.7
-
209
-
-
84896754721
-
Transcriptional repression of the transforming growth factor beta (TGF-beta) pseudoreceptor BMP and activin membrane-bound inhibitor (BAMBI) by nuclear factor kappaB (NF-kappaB) p50 enhances TGF-beta signaling in hepatic stellate cells
-
1:CAS:528:DC%2BC2cXjvVyktrc%3D 24448807 3945368
-
Liu C, Chen X, Yang L, Kisseleva T, Brenner DA, Seki E (2014) Transcriptional repression of the transforming growth factor beta (TGF-beta) pseudoreceptor BMP and activin membrane-bound inhibitor (BAMBI) by nuclear factor kappaB (NF-kappaB) p50 enhances TGF-beta signaling in hepatic stellate cells. J Biol Chem 289:7082-7091
-
(2014)
J Biol Chem
, vol.289
, pp. 7082-7091
-
-
Liu, C.1
Chen, X.2
Yang, L.3
Kisseleva, T.4
Brenner, D.A.5
Seki, E.6
-
210
-
-
84889886646
-
Targeting of alphav integrin identifies a core molecular pathway that regulates fibrosis in several organs
-
1:CAS:528:DC%2BC3sXhslCqsbjE 24216753
-
Henderson NC, Arnold TD, Katamura Y, Giacomini MM, Rodriguez JD, McCarty JH, Pellicoro A, Raschperger E, Betsholtz C, Ruminski PG, Griggs DW, Prinsen MJ, Maher JJ, Iredale JP, Lacy-Hulbert A, Adams RH, Sheppard D (2013) Targeting of alphav integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med 19:1617-1624
-
(2013)
Nat Med
, vol.19
, pp. 1617-1624
-
-
Henderson, N.C.1
Arnold, T.D.2
Katamura, Y.3
Giacomini, M.M.4
Rodriguez, J.D.5
McCarty, J.H.6
Pellicoro, A.7
Raschperger, E.8
Betsholtz, C.9
Ruminski, P.G.10
Griggs, D.W.11
Prinsen, M.J.12
Maher, J.J.13
Iredale, J.P.14
Lacy-Hulbert, A.15
Adams, R.H.16
Sheppard, D.17
-
211
-
-
0033067492
-
Transforming growth factor beta and tumor necrosis factor alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells
-
1:CAS:528:DyaK1MXksVOqsLc%3D 10385656
-
Saile B, Matthes N, Knittel T, Ramadori G (1999) Transforming growth factor beta and tumor necrosis factor alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells. Hepatology 30:196-202
-
(1999)
Hepatology
, vol.30
, pp. 196-202
-
-
Saile, B.1
Matthes, N.2
Knittel, T.3
Ramadori, G.4
-
212
-
-
78751585439
-
Hedgehog signaling in the liver
-
1:CAS:528:DC%2BC3MXmsVyrsg%3D%3D 21093090 3053023
-
Omenetti A, Choi S, Michelotti G, Diehl AM (2011) Hedgehog signaling in the liver. J Hepatol 54:366-373
-
(2011)
J Hepatol
, vol.54
, pp. 366-373
-
-
Omenetti, A.1
Choi, S.2
Michelotti, G.3
Diehl, A.M.4
-
213
-
-
84861573996
-
Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease
-
1:CAS:528:DC%2BC38XnsFOru7Y%3D 22213086 3499103
-
Guy CD, Suzuki A, Zdanowicz M, Abdelmalek MF, Burchette J, Unalp A, Diehl AM (2012) Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease. Hepatology 55:1711-1721
-
(2012)
Hepatology
, vol.55
, pp. 1711-1721
-
-
Guy, C.D.1
Suzuki, A.2
Zdanowicz, M.3
Abdelmalek, M.F.4
Burchette, J.5
Unalp, A.6
Diehl, A.M.7
-
214
-
-
84876727630
-
Hedgehog pathway and pediatric nonalcoholic fatty liver disease
-
1:CAS:528:DC%2BC3sXms1egsbw%3D 23300059 3637920
-
Swiderska-Syn M, Suzuki A, Guy CD, Schwimmer JB, Abdelmalek MF, Lavine JE, Diehl AM (2013) Hedgehog pathway and pediatric nonalcoholic fatty liver disease. Hepatology 57:1814-1825
-
(2013)
Hepatology
, vol.57
, pp. 1814-1825
-
-
Swiderska-Syn, M.1
Suzuki, A.2
Guy, C.D.3
Schwimmer, J.B.4
Abdelmalek, M.F.5
Lavine, J.E.6
Diehl, A.M.7
-
215
-
-
77954234732
-
Activation of Rac1 promotes hedgehog-mediated acquisition of the myofibroblastic phenotype in rat and human hepatic stellate cells
-
1:CAS:528:DC%2BC3cXpsFShtbs%3D 20578145 2920128
-
Choi SS, Witek RP, Yang L, Omenetti A, Syn WK, Moylan CA, Jung Y, Karaca GF, Teaberry VS, Pereira TA, Wang J, Ren XR, Diehl AM (2010) Activation of Rac1 promotes hedgehog-mediated acquisition of the myofibroblastic phenotype in rat and human hepatic stellate cells. Hepatology 52:278-290
-
(2010)
Hepatology
, vol.52
, pp. 278-290
-
-
Choi, S.S.1
Witek, R.P.2
Yang, L.3
Omenetti, A.4
Syn, W.K.5
Moylan, C.A.6
Jung, Y.7
Karaca, G.F.8
Teaberry, V.S.9
Pereira, T.A.10
Wang, J.11
Ren, X.R.12
Diehl, A.M.13
-
216
-
-
84887015586
-
Cross-talk between Notch and Hedgehog regulates hepatic stellate cell fate in mice
-
1:CAS:528:DC%2BC3sXhslWqsLbL 23703657 3758784
-
Xie G, Karaca G, Swiderska-Syn M, Michelotti GA, Kruger L, Chen Y, Premont RT, Choi SS, Diehl AM (2013) Cross-talk between Notch and Hedgehog regulates hepatic stellate cell fate in mice. Hepatology 58:1801-1813
-
(2013)
Hepatology
, vol.58
, pp. 1801-1813
-
-
Xie, G.1
Karaca, G.2
Swiderska-Syn, M.3
Michelotti, G.A.4
Kruger, L.5
Chen, Y.6
Premont, R.T.7
Choi, S.S.8
Diehl, A.M.9
-
217
-
-
32944478021
-
Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells
-
1:CAS:528:DC%2BD2MXhtlGns7rK 16317688
-
Aleffi S, Petrai I, Bertolani C, Parola M, Colombatto S, Novo E, Vizzutti F, Anania FA, Milani S, Rombouts K, Laffi G, Pinzani M, Marra F (2005) Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology 42:1339-1348
-
(2005)
Hepatology
, vol.42
, pp. 1339-1348
-
-
Aleffi, S.1
Petrai, I.2
Bertolani, C.3
Parola, M.4
Colombatto, S.5
Novo, E.6
Vizzutti, F.7
Anania, F.A.8
Milani, S.9
Rombouts, K.10
Laffi, G.11
Pinzani, M.12
Marra, F.13
-
218
-
-
9444223845
-
Leptin as a novel profibrogenic cytokine in hepatic stellate cells: Mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation
-
1:CAS:528:DC%2BD2cXotFGiu7o%3D 15319373 2924993
-
Saxena NK, Titus MA, Ding X, Floyd J, Srinivasan S, Sitaraman SV, Anania FA (2004) Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation. FASEB J 18:1612-1614
-
(2004)
FASEB J
, vol.18
, pp. 1612-1614
-
-
Saxena, N.K.1
Titus, M.A.2
Ding, X.3
Floyd, J.4
Srinivasan, S.5
Sitaraman, S.V.6
Anania, F.A.7
-
219
-
-
32944463507
-
Cytokines, STATs and liver disease
-
1:CAS:528:DC%2BD2MXlvFSisrg%3D 16191414
-
Gao B (2005) Cytokines, STATs and liver disease. Cell Mol Immunol 2:92-100
-
(2005)
Cell Mol Immunol
, vol.2
, pp. 92-100
-
-
Gao, B.1
-
220
-
-
10744228583
-
Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin
-
1:CAS:528:DC%2BD2cXhtVOqtg%3D%3D 14724832
-
Kamada Y, Tamura S, Kiso S, Matsumoto H, Saji Y, Yoshida Y, Fukui K, Maeda N, Nishizawa H, Nagaretani H, Okamoto Y, Kihara S, Miyagawa J, Shinomura Y, Funahashi T, Matsuzawa Y (2003) Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 125:1796-1807
-
(2003)
Gastroenterology
, vol.125
, pp. 1796-1807
-
-
Kamada, Y.1
Tamura, S.2
Kiso, S.3
Matsumoto, H.4
Saji, Y.5
Yoshida, Y.6
Fukui, K.7
Maeda, N.8
Nishizawa, H.9
Nagaretani, H.10
Okamoto, Y.11
Kihara, S.12
Miyagawa, J.13
Shinomura, Y.14
Funahashi, T.15
Matsuzawa, Y.16
-
221
-
-
84879474411
-
The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension
-
23323248 3540369
-
Seo YS, Shah VH (2012) The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension. Clin Mol Hepatol 18:337-346
-
(2012)
Clin Mol Hepatol
, vol.18
, pp. 337-346
-
-
Seo, Y.S.1
Shah, V.H.2
-
222
-
-
0032920540
-
Leaky gut in alcoholic cirrhosis: A possible mechanism for alcohol-induced liver damage
-
1:STN:280:DyaK1M7jtFCmtw%3D%3D 9934756
-
Keshavarzian A, Holmes EW, Patel M, Iber F, Fields JZ, Pethkar S (1999) Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Am J Gastroenterol 94:200-207
-
(1999)
Am J Gastroenterol
, vol.94
, pp. 200-207
-
-
Keshavarzian, A.1
Holmes, E.W.2
Patel, M.3
Iber, F.4
Fields, J.Z.5
Pethkar, S.6
-
223
-
-
35948958955
-
TLR4 enhances TGF-beta signaling and hepatic fibrosis
-
1:CAS:528:DC%2BD2sXht1Kmtr3O 17952090
-
Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, Schwabe RF (2007) TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13:1324-1332
-
(2007)
Nat Med
, vol.13
, pp. 1324-1332
-
-
Seki, E.1
De Minicis, S.2
Osterreicher, C.H.3
Kluwe, J.4
Osawa, Y.5
Brenner, D.A.6
Schwabe, R.F.7
-
224
-
-
84927644391
-
Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice
-
1:CAS:528:DC%2BC2MXktlWnsb8%3D 25466902 4422368
-
Mazagova M, Wang L, Anfora AT, Wissmueller M, Lesley SA, Miyamoto Y, Eckmann L, Dhungana S, Pathmasiri W, Sumner S, Westwater C, Brenner DA, Schnabl B (2015) Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice. FASEB J 29:1043-1055
-
(2015)
FASEB J
, vol.29
, pp. 1043-1055
-
-
Mazagova, M.1
Wang, L.2
Anfora, A.T.3
Wissmueller, M.4
Lesley, S.A.5
Miyamoto, Y.6
Eckmann, L.7
Dhungana, S.8
Pathmasiri, W.9
Sumner, S.10
Westwater, C.11
Brenner, D.A.12
Schnabl, B.13
-
225
-
-
84899474318
-
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice
-
23959503
-
De Minicis S, Rychlicki C, Agostinelli L, Saccomanno S, Candelaresi C, Trozzi L, Mingarelli E, Facinelli B, Magi G, Palmieri C, Marzioni M, Benedetti A, Svegliati-Baroni G (2014) Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice. Hepatology 59:1738-1749
-
(2014)
Hepatology
, vol.59
, pp. 1738-1749
-
-
De Minicis, S.1
Rychlicki, C.2
Agostinelli, L.3
Saccomanno, S.4
Candelaresi, C.5
Trozzi, L.6
Mingarelli, E.7
Facinelli, B.8
Magi, G.9
Palmieri, C.10
Marzioni, M.11
Benedetti, A.12
Svegliati-Baroni, G.13
-
226
-
-
84931027253
-
Role of serum toll-like receptors 2 and 4 in non-alcoholic steatohepatitis and liver fibrosis
-
1:CAS:528:DC%2BC2MXhtVWgsL7F 25684563
-
Cengiz M, Ozenirler S, Elbeg S (2015) Role of serum toll-like receptors 2 and 4 in non-alcoholic steatohepatitis and liver fibrosis. J Gastroenterol Hepatol 30:1190-1196
-
(2015)
J Gastroenterol Hepatol
, vol.30
, pp. 1190-1196
-
-
Cengiz, M.1
Ozenirler, S.2
Elbeg, S.3
-
227
-
-
84859444880
-
Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues
-
22240484 3439519
-
Hernandez-Gea V, Ghiassi-Nejad Z, Rozenfeld R, Gordon R, Fiel MI, Yue Z, Czaja MJ, Friedman SL (2012) Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology 142:938-946
-
(2012)
Gastroenterology
, vol.142
, pp. 938-946
-
-
Hernandez-Gea, V.1
Ghiassi-Nejad, Z.2
Rozenfeld, R.3
Gordon, R.4
Fiel, M.I.5
Yue, Z.6
Czaja, M.J.7
Friedman, S.L.8
-
228
-
-
84898987733
-
Vascular endothelial growth factor promotes fibrosis resolution and repair in mice
-
Yang L, Kwon J, Popov Y, Gajdos GB, Ordog T, Brekken RA, Mukhopadhyay D, Schuppan D, Bi Y, Simonetto D, Shah VH (2014) Vascular endothelial growth factor promotes fibrosis resolution and repair in mice. Gastroenterology 146(1339-1350):e1331
-
(2014)
Gastroenterology
, vol.146
, Issue.1339-1350
, pp. e1331
-
-
Yang, L.1
Kwon, J.2
Popov, Y.3
Gajdos, G.B.4
Ordog, T.5
Brekken, R.A.6
Mukhopadhyay, D.7
Schuppan, D.8
Bi, Y.9
Simonetto, D.10
Shah, V.H.11
-
229
-
-
84890571870
-
Angiogenesis in liver regeneration and fibrosis: "a double-edged sword"
-
26202026
-
Kaur S, Anita K (2013) Angiogenesis in liver regeneration and fibrosis: "a double-edged sword". Hepatol Int 7:959-968
-
(2013)
Hepatol Int
, vol.7
, pp. 959-968
-
-
Kaur, S.1
Anita, K.2
-
230
-
-
59349121044
-
Angiogenesis in liver disease
-
1:CAS:528:DC%2BD1MXhs1ekt7g%3D 19157625
-
Fernandez M, Semela D, Bruix J, Colle I, Pinzani M, Bosch J (2009) Angiogenesis in liver disease. J Hepatol 50:604-620
-
(2009)
J Hepatol
, vol.50
, pp. 604-620
-
-
Fernandez, M.1
Semela, D.2
Bruix, J.3
Colle, I.4
Pinzani, M.5
Bosch, J.6
-
231
-
-
33750607736
-
Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats
-
1:CAS:528:DC%2BD28XhtFyqsr3P 17006938
-
Kitade M, Yoshiji H, Kojima H, Ikenaka Y, Noguchi R, Kaji K, Yoshii J, Yanase K, Namisaki T, Asada K, Yamazaki M, Tsujimoto T, Akahane T, Uemura M, Fukui H (2006) Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats. Hepatology 44:983-991
-
(2006)
Hepatology
, vol.44
, pp. 983-991
-
-
Kitade, M.1
Yoshiji, H.2
Kojima, H.3
Ikenaka, Y.4
Noguchi, R.5
Kaji, K.6
Yoshii, J.7
Yanase, K.8
Namisaki, T.9
Asada, K.10
Yamazaki, M.11
Tsujimoto, T.12
Akahane, T.13
Uemura, M.14
Fukui, H.15
-
232
-
-
79960745146
-
Hypoxia-inducible transcription factor 2alpha promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis
-
1:CAS:528:DC%2BC3MXpt1yjur0%3D 21538443 3145012
-
Qu A, Taylor M, Xue X, Matsubara T, Metzger D, Chambon P, Gonzalez FJ, Shah YM (2011) Hypoxia-inducible transcription factor 2alpha promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis. Hepatology 54:472-483
-
(2011)
Hepatology
, vol.54
, pp. 472-483
-
-
Qu, A.1
Taylor, M.2
Xue, X.3
Matsubara, T.4
Metzger, D.5
Chambon, P.6
Gonzalez, F.J.7
Shah, Y.M.8
-
233
-
-
34447317835
-
Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells
-
1:CAS:528:DC%2BD2sXntlOhtL4%3D 17525262 1899450
-
Novo E, Cannito S, Zamara E, Valfre di Bonzo L, Caligiuri A, Cravanzola C, Compagnone A, Colombatto S, Marra F, Pinzani M, Parola M (2007) Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells. Am J Pathol 170:1942-1953
-
(2007)
Am J Pathol
, vol.170
, pp. 1942-1953
-
-
Novo, E.1
Cannito, S.2
Zamara, E.3
Valfre Di Bonzo, L.4
Caligiuri, A.5
Cravanzola, C.6
Compagnone, A.7
Colombatto, S.8
Marra, F.9
Pinzani, M.10
Parola, M.11
-
234
-
-
55249125669
-
Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis
-
1:CAS:528:DC%2BD1cXhsVOhtbvL 18823985
-
Taura K, De Minicis S, Seki E, Hatano E, Iwaisako K, Osterreicher CH, Kodama Y, Miura K, Ikai I, Uemoto S, Brenner DA (2008) Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis. Gastroenterology 135:1729-1738
-
(2008)
Gastroenterology
, vol.135
, pp. 1729-1738
-
-
Taura, K.1
De Minicis, S.2
Seki, E.3
Hatano, E.4
Iwaisako, K.5
Osterreicher, C.H.6
Kodama, Y.7
Miura, K.8
Ikai, I.9
Uemoto, S.10
Brenner, D.A.11
|